Congenital heart disease in the older adult: A scientific statement from the American heart association

Circulation

Volumn 131, Issue 21, 2015, Pages 1884-1931

  Bhatt, Ami B ^a   Foster, Elys ^a   Kuehl, Kare ^a   Alpert, Josep ^a   Brabeck, Stephe ^a   Crumb, Stephe ^a   Davidson, William R ^a   Earing, Michael G ^a   Ghoshhajra, Brian B ^a   Karamlou, Tar ^a   Mital, Seem ^a   Ting, Jennife ^a   Tseng, Zian H ^a  

^a NONE

Author keywords

AHA Scientific Statements; Cardiac arrhythmia; Cardiac imaging techniques; Cardiac surgical procedures; Cardiac valves; Congenital heart defect; Heart failure

Indexed keywords

ADULTHOOD; AGING; AORTA COARCTATION; AORTA VALVE REGURGITATION; ARTICLE; ATRIAL FIBRILLATION; ATRIOVENTRICULAR BLOCK; ATRIOVENTRICULAR SEPTAL DEFECT; BICUSPID AORTIC VALVE; BRADYCARDIA; CANCER RISK; CANCER SCREENING; CARDIAC PATIENT; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR RISK; CHILDHOOD; COMPUTER ASSISTED TOMOGRAPHY; CONGENITAL HEART DISEASE; CORONARY ARTERY ANOMALY; DEMENTIA; DIABETES MELLITUS; EBSTEIN ANOMALY; ELECTROPHYSIOLOGICAL PROCEDURES; EXERCISE TEST; FALLOT TETRALOGY; GENETIC COUNSELING; GENETIC RISK; GENETIC SCREENING; GREAT VESSELS TRANSPOSITION; HEART ATRIUM SEPTUM DEFECT; HEART CATHETERIZATION; HEART FAILURE; HEART SINGLE VENTRICLE; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; KIDNEY DISEASE; LIVER DISEASE; LUNG FUNCTION; LUNG VEIN DRAINAGE ANOMALY; MEDICAL SOCIETY; META ANALYSIS (TOPIC); MORBIDITY; MULTICENTER STUDY (TOPIC); OUTCOME ASSESSMENT; PATHOGENESIS; PATIENT CARE; PRIORITY JOURNAL; PULMONARY VALVE INSUFFICIENCY; PULMONARY VALVE STENOSIS; PULMONARY VASCULAR DISEASE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENCE RISK; RIGHT VENTRICLE TO PULMONARY ARTERY CONDUIT; SEXUAL DYSFUNCTION; SINOATRIAL NODAL REENTRY TACHYCARDIA; STRESS ECHOCARDIOGRAPHY; SURVIVAL; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRICUSPID VALVE REGURGITATION; WOLFF PARKINSON WHITE SYNDROME; ADULT; AGED; ARRHYTHMIAS, CARDIAC; CARDIOVASCULAR SYSTEM EXAMINATION; COMORBIDITY; COMPLICATION; DELAYED DIAGNOSIS; DISEASE MANAGEMENT; HEART DEFECTS, CONGENITAL; HYPERTENSION, PULMONARY; MIDDLE AGED; PRACTICE GUIDELINE; PREVALENCE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ARRHYTHMIAS, CARDIAC; COMORBIDITY; DELAYED DIAGNOSIS; DIAGNOSTIC TECHNIQUES, CARDIOVASCULAR; DISEASE MANAGEMENT; GENETIC COUNSELING; HEART DEFECTS, CONGENITAL; HEART FAILURE; HUMANS; HYPERTENSION, PULMONARY; MIDDLE AGED; PREVALENCE;

EID: 84936135453     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIR.0000000000000204     Document Type: Article

References (422)

1. Verheugt CL, Uiterwaal CS, van der Velde ET, Meijboom FJ, Pieper PG, van Dijk AP, Vliegen HW, Grobbee DE, Mulder BJ. Mortality in adult congenital heart disease. Eur Heart J. 2010;31:1220-1229. doi: 10.1093/ eurheartj/ehq032.
2. Marelli AJ, Mackie AS, Ionescu-Ittu R, Rahme E, Pilote L. Congenital heart disease in the general population: changing prevalence and age distribution. Circulation. 2007;115:163-172. doi: 10.1161/ CIRCULATIONAHA.106.627224.
3. Hoffman JI. Congenital heart disease: incidence and inheritance. Pediatr Clin North Am. 1990;37:25-43.
4. Brickner ME, Hillis LD, Lange RA. Congenital heart disease in adults: first of two parts. N Engl J Med. 2000;342:256-263. doi: 10.1056/ NEJM200001273420407.
5. Perloff JK, Warnes CA. Challenges posed by adults with repaired congenital heart disease. Circulation. 2001;103:2637-2643. doi: 10.1161/01. CIR.103.21.2637.
6. Niwa K, Perloff JK, Webb GD, Murphy D, Liberthson R, Warnes CA, Gatzoulis MA. Survey of specialized tertiary care facilities for adults with congenital heart disease. Int J Cardiol. 2004;96:211-216. doi: 10.1016/j. ijcard.2003.06.019.
7. Warnes CA, Liberthson R, Danielson GK, Dore A, Harris L, Hoffman JI, Somerville J, Williams RG, Webb GD. Task force 1: the changing profile of congenital heart disease in adult life. J Am Coll Cardiol. 2001;37:1170-1175.
8. Ferencz C, Loffredo C, Correa-Villasenor A, Wilson PD, eds. Perspective in Pediatric Cardiology: Volume 5: Genetic and Environmental Risk Factors of Major Cardiovascular Malformations. Armonk, NY: Futura Publishing 1997.
9. Gilboa SM, Salemi JL, Nembhard WN, Fixler DE, Correa A. Mortality resulting from congenital heart disease among children and adults in the United States, 1999 to 2006. Circulation. 2010;122:2254-2263. doi: 10.1161/CIRCULATIONAHA.110.947002.
10. Khairy P, Ionescu-Ittu R, Mackie AS, Abrahamowicz M, Pilote L, Marelli AJ. Changing mortality in congenital heart disease. J Am Coll Cardiol. 2010;56:1149-1157. doi: 10.1016/j.jacc.2010.03.085.
11. Moons P, Bovijn L, Budts W, Belmans A, Gewillig M. Temporal trends in survival to adulthood among patients born with congenital heart disease from 1970 to 1992 in Belgium. Circulation. 2010;122:2264-2272. doi: 10.1161/CIRCULATIONAHA.110.946343.
12. Verheugt CL, Uiterwaal CS, van der Velde ET, Meijboom FJ, Pieper PG, Sieswerda GT, Plokker HW, Grobbee DE, Mulder BJ. The emerging burden of hospital admissions of adults with congenital heart disease. Heart. 2010;96:872-878. doi: 10.1136/hrt.2009.185595.
13. Rodriguez FH 3rd, Moodie DS, Parekh DR, Franklin WJ, Morales DL, Zafar F, Adams GJ, Friedman RA, Rossano JW. Outcomes of heart failurerelated hospitalization in adults with congenital heart disease in the United States. Congenit Heart Dis. 2013;8:513-519. doi: 10.1111/chd.12019.
14. Bouchardy J, Therrien J, Pilote L, Ionescu-Ittu R, Martucci G, Bottega N, Marelli AJ. Atrial arrhythmias in adults with congenital heart disease. Circulation. 2009;120:1679-1686. doi: 10.1161/ CIRCULATIONAHA.109.866319.
15. Pillutla P, Shetty KD, Foster E. Mortality associated with adult congenital heart disease: trends in the US population from 1979 to 2005. Am Heart J. 2009;158:874-879. doi: 10.1016/j.ahj.2009.08.014.
16. Nieminen HP, Jokinen EV, Sairanen HI. Late results of pediatric cardiac surgery in Finland: a population-based study with 96% follow-up. Circulation. 2001;104:570-575. doi: 10.1161/hc3101.093968.
17. Hoohenkerk GJ, Bruggemans EF, Koolbergen DR, Rijlaarsdam ME, Hazekamp MG. Long-term results of reoperation for left atrioventricular valve regurgitation after correction of atrioventricular septal defects. Ann Thorac Surg. 2012;93:849-855. doi: 10.1016/j. athoracsur.2011.09.043.
18. Welke KF, Morris CD, King E, Komanapalli C, Reller MD, Ungerleider RM. Population-based perspective of long-term outcomes after surgical repair of partial atrioventricular septal defect. Ann Thorac Surg. 2007;84:624-628.
19. Malhotra SP, Lacour-Gayet F, Mitchell MB, Clarke DR, Dines ML, Campbell DN. Reoperation for left atrioventricular valve regurgitation after atrioventricular septal defect repair. Ann Thorac Surg. 2008;86:147-151. doi: 10.1016/j.athoracsur.2008.03.040.
20. Tweddell JS, Simpson P, Li SH, Dunham-Ingle J, Bartz PJ, Earing MG, Pelech AN. Timing and technique of pulmonary valve replacement in the patient with tetralogy of Fallot. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2012;15:27-33. doi: 10.1053/j.pcsu.2012.01.007.
21. Kim HW, Seo DM, Shin HJ, Park JJ, Yoon TJ. Long term results of right ventricular outflow tract reconstruction with homografts. Korean J Thorac Cardiovasc Surg. 2011;44:108-114. doi: 10.5090/kjtcs.2011.44.2.108.
22. Tadros TM, Klein MD, Shapira OM. Ascending aortic dilatation associated with bicuspid aortic valve: pathophysiology, molecular biology, and clinical implications. Circulation. 2009;119:880-890. doi: 10.1161/ CIRCULATIONAHA.108.795401.
23. Kappetein AP, Zwinderman AH, Bogers AJ, Rohmer J, Huysmans HA. More than thirty-five years of coarctation repair: an unexpected high relapse rate. J Thorac Cardiovasc Surg. 1994;107:87-95.
24. Roifman I, Therrien J, Ionescu-Ittu R, Pilote L, Guo L, Kotowycz MA, Martucci G, Marelli AJ. Coarctation of the aorta and coronary artery disease: fact or fiction? Circulation. 2012;126:16-21. doi: 10.1161/ CIRCULATIONAHA.111.088294.
25. Anagnostopoulos PV, Johnson NC, Robertson L, Sapru A, Azakie A. Surgical management of left ventricular outflow tract obstruction. J Card Surg. 2012;27:103-111. doi: 10.1111/j.1540-8191.2011.01359.x.
26. de Lezo JS, Romero M, Segura J, Pan M, de Lezo JS, Pavlovic D, Mazuelos F, Delgado M, Mesa D. Long-term outcome of patients with isolated thin discrete subaortic stenosis treated by balloon dilation: a 25-year study. Circulation. 2011;124:1461-1468. doi: 10.1161/ CIRCULATIONAHA.111.019448.
27. Laksman ZW, Silversides CK, Sedlak T, Samman AM, Williams WG, Webb GD, Liu PP. Valvular aortic stenosis as a major sequelae in patients with pre-existing subaortic stenosis changing spectrum of outcomes. J Am Coll Cardiol. 2011;58:962-965. doi: 10.1016/j.jacc.2011.04.029.
28. Graham TP Jr, Bernard YD, Mellen BG, Celermajer D, Baumgartner H, Cetta F, Connolly HM, Davidson WR, Dellborg M, Foster E, Gersony WM, Gessner IH, Hurwitz RA, Kaemmerer H, Kugler JD, Murphy DJ, Noonan JA, Morris C, Perloff JK, Sanders SP, Sutherland JL. Long-term outcome in congenitally corrected transposition of the great arteries: a multi-institutional study. J Am Coll Cardiol. 2000;36:255-261.
29. Roubertie F, Thambo JB, Bretonneau A, Iriart X, Laborde N, Baudet E, Roques X. Late outcome of 132 Senning procedures after 20 years of follow-up. Ann Thorac Surg. 2011;92:2206-2213. doi: 10.1016/j. athoracsur.2011.06.024.
30. Hörer J, Schreiber C, Cleuziou J, Vogt M, Prodan Z, Busch R, Holper K, Lange R. Improvement in long-term survival after hospital discharge but not in freedom from reoperation after the change from atrial to arterial switch for transposition of the great arteries. J Thorac Cardiovasc Surg. 2009;137:347-354. doi: 10.1016/j.jtcvs.2008.09.015.
31. Lange R, Hörer J, Kostolny M, Cleuziou J, Vogt M, Busch R, Holper K, Meisner H, Hess J, Schreiber C. Presence of a ventricular septal defect and the Mustard operation are risk factors for late mortality after the atrial switch operation: thirty years of follow-up in 417 patients at a single center. Circulation. 2006;114:1905-1913. doi: 10.1161/ CIRCULATIONAHA.105.606046.
32. Attenhofer Jost CH, Bombeli T, Schrimpf C, Oechslin E, Kiowski W, Jenni R. Extensive thrombus formation in the right ventricle due to a rare combination of arrhythmogenic right ventricular cardiomyopathy and heterozygous prothrombin gene mutation G20210 A. Cardiology. 2000;93:127-130. doi: 10.1159/000007014.
33. Wilson NJ, Clarkson PM, Barratt-Boyes BG, Calder AL, Whitlock RM, Easthope RN, Neutze JM. Long-term outcome after the Mustard repair for simple transposition of the great arteries: 28-year follow-up. J Am Coll Cardiol. 1998;32:758-765.
34. Krieger EV, Moko LE, Wu F, Landzberg MJ, Valente AM, Assenza GE, Ukomadu C, Opotowsky AR. Single ventricle anatomy is associated with increased frequency of nonalcoholic cirrhosis. Int J Cardiol. 2013;167:1918-1923. doi: 10.1016/j.ijcard.2012.05.002.
35. Engelfriet P, Boersma E, Oechslin E, Tijssen J, Gatzoulis MA, Thilén U, Kaemmerer H, Moons P, Meijboom F, Popelová J, Laforest V, Hirsch R, Daliento L, Thaulow E, Mulder B. The spectrum of adult congenital heart disease in Europe: morbidity and mortality in a 5 year follow-up period: the Euro Heart Survey on adult congenital heart disease. Eur Heart J. 2005;26:2325-2333. doi: 10.1093/eurheartj/ehi396.
36. Hanninen M, Kmet A, Taylor DA, Ross DB, Rebeyka I, Vonder Muhll IF. Atrial septal defect closure in the elderly is associated with excellent quality of life, functional improvement, and ventricular remodelling. Can J Cardiol. 2011;27:698-704. doi: 10.1016/j.cjca.2011.04.003.
37. Nyboe C, Fenger-Grøn M, Nielsen-Kudsk JE, Hjortdal V. Closure of secundum atrial septal defects in the adult and elderly patients. Eur J Cardiothorac Surg. 2013;43:752-757. doi: 10.1093/ejcts/ezs405.
38. Park JJ, Lee SC, Kim JB, Seo DJ, Song JM, Yun SC, Yun TJ. Deterioration of mitral valve competence after the repair of atrial septal defect in adults. Ann Thorac Surg. 2011;92:1629-1633. doi: 10.1016/j. athoracsur.2011.05.118.
39. Hannoush H, Tamim H, Younes H, Arnaout S, Gharzeddine W, Dakik H, Obeid M, Bitar FF. Patterns of congenital heart disease in unoperated adults: a 20-year experience in a developing country. Clin Cardiol. 2004;27:236-240.
40. Attenhofer Jost CH, Connolly HM, Burkhart HM, Scott CG, Dearani JA, Carroll AJ, Tajik AJ. Tetralogy of Fallot repair in patients 40 years or older. Mayo Clin Proc. 2010;85:1090-1094. doi: 10.4065/ mcp.2010.0286.
41. Beauchesne LM, Warnes CA, Connolly HM, Ammash NM, Tajik AJ, Danielson GK. Outcome of the unoperated adult who presents with congenitally corrected transposition of the great arteries. J Am Coll Cardiol. 2002;40:285-290.
42. Yamanaka O, Hobbs RE. Coronary artery anomalies in 126,595 patients undergoing coronary arteriography. Cathet Cardiovasc Diagn. 1990;21:28-40.
43. Alexander RW, Griffith GC. Anomalies of the coronary arteries and their clinical significance. Circulation. 1956;14:800-805.
44. Roberts WC. Major anomalies of coronary arterial origin seen in adulthood. Am Heart J. 1986;111:941-963.
45. Taylor AJ, Rogan KM, Virmani R. Sudden cardiac death associated with isolated congenital coronary artery anomalies. J Am Coll Cardiol. 1992;20:640-647.
46. Frescura C, Basso C, Thiene G, Corrado D, Pennelli T, Angelini A, Daliento L. Anomalous origin of coronary arteries and risk of sudden death: a study based on an autopsy population of congenital heart disease. Hum Pathol. 1998;29:689-695.
47. Liberthson RR, Dinsmore RE, Fallon JT. Aberrant coronary artery origin from the aorta: report of 18 patients, review of literature and delineation of natural history and management. Circulation. 1979;59:748-754.
48. Kaushal S, Backer CL, Popescu AR, Walker BL, Russell HM, Koenig PR, Rigsby CK, Mavroudis C. Intramural coronary length correlates with symptoms in patients with anomalous aortic origin of the coronary artery. Ann Thorac Surg. 2011;92:986-991. doi: 10.1016/j. athoracsur.2011.04.112.
49. Warnes CA, Williams RG, Bashore TM, Child JS, Connolly HM, Dearani JA, del Nido P, Fasules JW, Graham TP Jr, Hijazi ZM, Hunt SA, King ME, Landzberg MJ, Miner PD, Radford MJ, Walsh EP, Webb GD. ACC/ AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease). Circulation. 2008;118:e714-e833. doi: 10.1161/ CIRCULATIONAHA.108.190690.
50. Stulak JM, Dearani JA, Burkhart HM, Sundt TM, Connolly HM, Schaff HV. Does the dilated ascending aorta in an adult with congenital heart disease require intervention? J Thorac Cardiovasc Surg. 2010;140(suppl):S52-S57. doi: 10.1016/j.jtcvs.2010.08.052.
51. Berenson GS, Srinivasan SR, Bao W, Newman WP 3rd, Tracy RE, Wattigney WA. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults: the Bogalusa Heart Study. N Engl J Med. 1998;338:1650-1656. doi: 10.1056/ NEJM199806043382302.
52. Moons P, Van Deyk K, Dedroog D, Troost E, Budts W. Prevalence of cardiovascular risk factors in adults with congenital heart disease. Eur J Cardiovasc Prev Rehabil. 2006;13:612-616. doi: 10.1097/01. hjr.0000197472.81694.2b.
53. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report [published correction appears in JAMA. 2003;290:197]. JAMA. 2003;289:2560-2572. doi: 10.1001/jama.289.19.2560.
54. Yoon SS, Ostchega Y, Louis T. Recent trends in the prevalence of high blood pressure and its treatment and control, 1999-2008. NCHS Data Brief. 2010 Oct:1-8.
55. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, Carnethon MR, Dai S, de Simone G, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Greenlund KJ, Hailpern SM, Heit JA, Ho PM, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli A, Matchar DB, McDermott MM, Meigs JB, Moy CS, Mozaffarian D, Mussolino ME, Nichol G, Paynter NP, Rosamond WD, Sorlie PD, Stafford RS, Turan TN, Turner MB, Wong ND, Wylie-Rosett J; on behalf of the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2011 update: a report from the American Heart Association [published corrections appear in Circulation. 2011;123:e240 and Circulation. 2011;124:e426]. Circulation. 2011;123:e18-e209. doi: 10.1161/CIR.0b013e3182009701.
56. Billett J, Cowie MR, Gatzoulis MA, Vonder Muhll IF, Majeed A. Comorbidity, healthcare utilisation and process of care measures in patients with congenital heart disease in the UK: cross-sectional, population-based study with case-control analysis. Heart. 2008;94:1194-1199. doi: 10.1136/hrt.2007.122671.
57. Afilalo J, Therrien J, Pilote L, Ionescu-Ittu R, Martucci G, Marelli AJ. Geriatric congenital heart disease: burden of disease and predictors of mortality. J Am Coll Cardiol. 2011;58:1509-1515. doi: 10.1016/j. jacc.2011.06.041.
58. Flanagan MF, Hourihan M, Keane JF. Incidence of renal dysfunction in adults with cyanotic congenital heart disease. Am J Cardiol. 1991;68:403-406.
59. Webb G. Treatment of coarctation and late complications in the adult. Semin Thorac Cardiovasc Surg. 2005;17:139-142. doi: 10.1053/j. semtcvs.2005.03.001.
60. Kenny D, Hijazi ZM. Coarctation of the aorta: from fetal life to adulthood. Cardiol J. 2011;18:487-495.
61. Pearson D, Rodriquez E, Fernandes S. Prevalence of obesity in adults with congenital heart disease. In: Program and abstracts of the Fifth National Conference of the Adult Congenital Heart Association. Philadelphia, PA: Adult Congenital Heart Association; May 1-4, 2008. Abstract.
62. Aronow WS, Fleg JL, Pepine CJ, Artinian NT, Bakris G, Brown AS, Ferdinand KC, Forciea MA, Frishman WH, Jaigobin C, Kostis JB, Mancia G, Oparil S, Ortiz E, Reisin E, Rich MW, Schocken DD, Weber MA, Wesley DJ, Harrington RA; ACCF Task Force. ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents [published corrections appear in Circulation. 2011;123:e616 and Circulation. 2011;124:e175]. Circulation. 2011;123:2434-2506. doi: 10.1161/CIR.0b013e31821daaf6.
63. Beckett NS, Peters R, Fletcher AE, Staessen JA, Liu L, Dumitrascu D, Stoyanovsky V, Antikainen RL, Nikitin Y, Anderson C, Belhani A, Forette F, Rajkumar C, Thijs L, Banya W, Bulpitt CJ; HYVET Study Group. Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008;358:1887-1898. doi: 10.1056/NEJMoa0801369.
64. Perloff JK, Latta H, Barsotti P. Pathogenesis of the glomerular abnormality in cyanotic congenital heart disease. Am J Cardiol. 2000;86:1198-1204.
65. Tanous D, Benson LN, Horlick EM. Coarctation of the aorta: evaluation and management. Curr Opin Cardiol. 2009;24:509-515. doi: 10.1097/ HCO.0b013e328330cc22.
66. Brooke BS, Habashi JP, Judge DP, Patel N, Loeys B, Dietz HC 3rd. Angiotensin II blockade and aortic-root dilation in Marfan's syndrome. N Engl J Med. 2008;358:2787-2795. doi: 10.1056/NEJMoa0706585.
67. Woodmansey PA, Yeo WW, Jackson PR, Ramsay LE. Acute renal failure with ACE inhibition in aortic coarctation. Postgrad Med J. 1994;70:927-929.
68. Anwar AJ, Walker JD, Frier BM. Type 1 diabetes mellitus and Down's syndrome: prevalence, management and diabetic complications. Diabet Med. 1998;15:160-163. doi: 10.1002/ (SICI)1096-9136(199802)15:23.0.CO;2-J. 160::AID-DIA5373.0.CO;2-J
69. Hait G, Corpus M, Lamarre FR, Yuan SH, Kypson J, Cheng G. Alteration of glucose and insulin metabolism in congenital heart disease. Circulation. 1972;46:333-346.
70. Ohuchi H, Miyamoto Y, Yamamoto M, Ishihara H, Takata H, Miyazaki A, Yamada O, Yagihara T. High prevalence of abnormal glucose metabolism in young adult patients with complex congenital heart disease. Am Heart J. 2009;158:30-39. doi: 10.1016/j.ahj.2009.04.021.
71. Lundell KH, Sabel KG, Eriksson BO, Mellgren G. Glucose metabolism and insulin secretion in children with cyanotic congenital heart disease. Acta Paediatr. 1997;86:1082-1084.
72. American Diabetes Association. Standards of medical care in diabetes-2011. Diabetes Care. 2011;34(suppl 1):S11-S61.
73. Giannakoulas G, Dimopoulos K, Engel R, Goktekin O, Kucukdurmaz Z, Vatankulu MA, Bedard E, Diller GP, Papaphylactou M, Francis DP, Di Mario C, Gatzoulis MA. Burden of coronary artery disease in adults with congenital heart disease and its relation to congenital and traditional heart risk factors. Am J Cardiol. 2009;103:1445-1450. doi: 10.1016/j.amjcard.2009.01.353.
74. Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith Jr.S.C., Stone NJ; National Heart, Lung, and Blood Institute; American College of Cardiology Foundation; American Heart Association. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines [published correction appears in Circulation. 2004;110:763]. Circulation. 2004;110:227-239. doi: 10.1161/01.CIR.0000133317.49796.0E.
75. Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, Goldberg AC, Gordon D, Levy D, Lloyd-Jones DM, McBride P, Schwartz JS, Shero ST, Smith Jr.S.C., Watson K, Wilson PW, Eddleman KM, Jarrett NM, LaBresh K, Nevo L, Wnek J, Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Curtis LH, DeMets D, Hochman JS, Kovacs RJ, Ohman EM, Pressler SJ, Sellke FW, Shen WK, Smith Jr.S.C., Tomaselli GF; American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines [published correction appears in Circulation. 2014;129(suppl 2):S46-S48]. Circulation. 2014;129(suppl 2):S1-S45. doi: 10.1161/01.cir.0000437738.63853.7a.
76. Kondo C, Nakazawa M, Momma K, Kusakabe K. Sympathetic denervation and reinnervation after arterial switch operation for complete transposition. Circulation. 1998;97:2414-2419.
77. Gagliardi MG, Adorisio R, Crea F, Versacci P, Di Donato R, Sanders SP. Abnormal vasomotor function of the epicardial coronary arteries in children five to eight years after arterial switch operation: an angiographic and intracoronary Doppler flow wire study. J Am Coll Cardiol. 2005;46:1565-1572. doi: 10.1016/j.jacc.2005.06.065.
78. Pasquali SK, Marino BS, Powell DJ, McBride MG, Paridon SM, Meyers KE, Mohler ER, Walker SA, Kren S, Cohen MS. Following the arterial switch operation, obese children have risk factors for early cardiovascular disease. Congenit Heart Dis. 2010;5:16-24. doi: 10.1111/j.1747-0803.2009.00359.x.
79. Gilmanov D, Bevilacqua S, Mazzone A, Glauber M. Do statins slow the process of calcification of aortic tissue valves? Interact Cardiovasc Thorac Surg. 2010;11:297-301. doi: 10.1510/icvts.2009.230920.
80. Paraskevas KI, Mikhailidis DP. Statins may not prevent structural valve degeneration of aortic bioprosthetic valves, but should probably be prescribed to patients undergoing heart valve surgery nonetheless. Interact Cardiovasc Thorac Surg. 2010;11:302. doi: 10.1510/ icvts.2009.230920B.
81. Piran S, Veldtman G, Siu S, Webb GD, Liu PP. Heart failure and ventricular dysfunction in patients with single or systemic right ventricles. Circulation. 2002;105:1189-1194. doi: 10.1161/hc1002.105182.
82. Lane DA, Chong AY, Lip GY. Psychological interventions for depression in heart failure. Cochrane Database Syst Rev. 2005;(1):CD003329.
83. Norozi K, Buchhorn R, Wessel A, Bahlmann J, Raab B, Geyer S, Kuehne T, Beibei L, Werdan K, Loppnow H. Beta-blockade does not alter plasma cytokine concentrations and ventricular function in young adults with right ventricular dysfunction secondary to operated congenital heart disease. Circ J. 2008;72:747-752.
84. Dore A, Houde C, Chan KL, Ducharme A, Khairy P, Juneau M, Marcotte F, Mercier LA. Angiotensin receptor blockade and exercise capacity in adults with systemic right ventricles: a multicenter, randomized, placebo-controlled clinical trial. Circulation. 2005;112:2411-2416. doi: 10.1161/CIRCULATIONAHA.105.543470.
85. Doughan AR, McConnell ME, Book WM. Effect of beta blockers (carvedilol or metoprolol XL) in patients with transposition of great arteries and dysfunction of the systemic right ventricle. Am J Cardiol. 2007;99:704-706. doi: 10.1016/j.amjcard.2006.10.025.
86. Puley G, Siu S, Connelly M, Harrison D, Webb G, Williams WG, Harris L. Arrhythmia and survival in patients 18 years of age after the Mustard procedure for complete transposition of the great arteries. Am J Cardiol. 1999;83:1080-1084.
87. Hechter SJ, Fredriksen PM, Liu P, Veldtman G, Merchant N, Freeman M, Therrien J, Benson L, Siu S, Webb G. Angiotensin-converting enzyme inhibitors in adults after the Mustard procedure. Am J Cardiol. 2001;87:660-663, A11.
88. Robinson B, Heise CT, Moore JW, Anella J, Sokoloski M, Eshaghpour E. Afterload reduction therapy in patients following intraatrial baffle operation for transposition of the great arteries. Pediatr Cardiol. 2002;23:618-623. doi: 10.1007/s00246-002-0046-2.
89. van der Bom T, Winter MM, Bouma BJ, Groenink M, Vliegen HW, Pieper PG, van Dijk AP, Sieswerda GT, Roos-Hesselink JW, Zwinderman AH, Mulder BJ. Effect of valsartan on systemic right ventricular function: a double-blind, randomized, placebo-controlled pilot trial. Circulation. 2013;127:322-330. doi: 10.1161/ CIRCULATIONAHA.112.135392.
90. Presbitero P, Somerville J, Rabajoli F, Stone S, Conte MR. Corrected transposition of the great arteries without associated defects in adult patients: clinical profile and follow up. Br Heart J. 1995;74:57-59.
91. van Son JA, Danielson GK, Huhta JC, Warnes CA, Edwards WD, Schaff HV, Puga FJ, Ilstrup DM. Late results of systemic atrioventricular valve replacement in corrected transposition. J Thorac Cardiovasc Surg. 1995;109:642-652.
92. Leon AR, Greenberg JM, Kanuru N, Baker CM, Mera FV, Smith AL, Langberg JJ, DeLurgio DB. Cardiac resynchronization in patients with congestive heart failure and chronic atrial fibrillation: effect of upgrading to biventricular pacing after chronic right ventricular pacing. J Am Coll Cardiol. 2002;39:1258-1263.
93. Dubin AM, Feinstein JA, Reddy VM, Hanley FL, Van Hare GF, Rosenthal DN. Electrical resynchronization: a novel therapy for the failing right ventricle. Circulation. 2003;107:2287-2289. doi: 10.1161/01. CIR.0000070930.33499.9F.
94. Taylor DO, Edwards LB, Mohacsi PJ, Boucek MM, Trulock EP, Keck BM, Hertz MI. The registry of the International Society for Heart and Lung Transplantation: twentieth official adult heart transplant report-2003. J Heart Lung Transplant. 2003;22:616-624.
95. Lamour JM, Addonizio LJ, Galantowicz ME, Quaegebeur JM, Mancini DM, Kichuk MR, Beniaminovitz A, Michler RE, Weinberg A, Hsu DT. Outcome after orthotopic cardiac transplantation in adults with congenital heart disease. Circulation. 1999;100(suppl):II200-II205.
96. Gamba A, Merlo M, Fiocchi R, Terzi A, Mammana C, Sebastiani R, Ferrazzi P. Heart transplantation in patients with previous Fontan operations. J Thorac Cardiovasc Surg. 2004;127:555-562. doi: 10.1016/j. jtcvs.2003.08.016.
97. Waddell TK, Bennett L, Kennedy R, Todd TR, Keshavjee SH. Heartlung or lung transplantation for Eisenmenger syndrome. J Heart Lung Transplant. 2002;21:731-737.
98. Abadir S, Khairy P. Electrophysiology and adult congenital heart disease: advances and options. Prog Cardiovasc Dis. 2011;53:281-292. doi: 10.1016/j.pcad.2010.07.003.
99. Walsh EP. Interventional electrophysiology in patients with congenital heart disease. Circulation. 2007;115:3224-3234. doi: 10.1161/ CIRCULATIONAHA.106.655753.
100. Fishberger SB, Wernovsky G, Gentles TL, Gauvreau K, Burnett J, Mayer Jr.J.E., Walsh EP. Factors that influence the development of atrial flutter after the Fontan operation. J Thorac Cardiovasc Surg. 1997;113:80-86.
101. Walsh EP, Rockenmacher S, Keane JF, Hougen TJ, Lock JE, Castaneda AR. Late results in patients with tetralogy of Fallot repaired during infancy. Circulation. 1988;77:1062-1067.
102. Delacretaz E, Ganz LI, Soejima K, Friedman PL, Walsh EP, Triedman JK, Sloss LJ, Landzberg MJ, Stevenson WG. Multiple atrial macro-reentry circuits in adults with repaired congenital heart disease: entrainment mapping combined with three-dimensional electroanatomic mapping. J Am Coll Cardiol. 2001;37:1665-1676.
103. Triedman JK, Alexander ME, Berul CI, Bevilacqua LM, Walsh EP. Electroanatomic mapping of entrained and exit zones in patients with repaired congenital heart disease and intra-atrial reentrant tachycardia. Circulation. 2001;103:2060-2065.
104. Triedman JK, Alexander ME, Love BA, Collins KK, Berul CI, Bevilacqua LM, Walsh EP. Influence of patient factors and ablative technologies on outcomes of radiofrequency ablation of intra-atrial reentrant tachycardia in patients with congenital heart disease. J Am Coll Cardiol. 2002;39:1827-1835.
105. Jaïs P, Shah DC, Haïssaguerre M, Hocini M, Garrigue S, Le Metayer P, Clémenty J. Prospective randomized comparison of irrigated-tip versus conventional-tip catheters for ablation of common flutter. Circulation. 2000;101:772-776. doi: 10.1161/01.CIR.101.7.772.
106. Triedman JK, DeLucca JM, Alexander ME, Berul CI, Cecchin F, Walsh EP. Prospective trial of electroanatomically guided, irrigated catheter ablation of atrial tachycardia in patients with congenital heart disease. Heart Rhythm. 2005;2:700-705. doi: 10.1016/j.hrthm.2005.03.017.
107. Reich JD, Auld D, Hulse E, Sullivan K, Campbell R. The Pediatric Radiofrequency Ablation Registry's experience with Ebstein's anomaly. Pediatric Electrophysiology Society. J Cardiovasc Electrophysiol. 1998;9:1370-1377.
108. Khositseth A, Danielson GK, Dearani JA, Munger TM, Porter CJ. Supraventricular tachyarrhythmias in Ebstein anomaly: management and outcome. J Thorac Cardiovasc Surg. 2004;128:826-833. doi: 10.1016/j.jtcvs.2004.02.012.
109. Chetaille P, Walsh EP, Triedman JK. Outcomes of radiofrequency catheter ablation of atrioventricular reciprocating tachycardia in patients with congenital heart disease. Heart Rhythm. 2004;1:168-173. doi: 10.1016/j.hrthm.2004.03.064.
110. Flinn CJ, Wolff GS, Dick M 2nd, Campbell RM, Borkat G, Casta A, Hordof A, Hougen TJ, Kavey RE, Kugler J, Liebman J, Greenhouse J, Hees P. Cardiac rhythm after the Mustard operation for complete transposition of the great arteries. N Engl J Med. 1984;310:1635-1638. doi: 10.1056/NEJM198406213102504.
111. Nakagawa H, Shah N, Matsudaira K, Overholt E, Chandrasekaran K, Beckman KJ, Spector P, Calame JD, Rao A, Hasdemir C, Otomo K, Wang Z, Lazzara R, Jackman WM. Characterization of reentrant circuit in macroreentrant right atrial tachycardia after surgical repair of congenital heart disease: isolated channels between scars allow "focal" ablation. Circulation. 2001;103:699-709. doi: 10.1161/01.CIR.103.5.699.
112. Triedman JK, Bergau DM, Saul JP, Epstein MR, Walsh EP. Efficacy of radiofrequency ablation for control of intraatrial reentrant tachycardia in patients with congenital heart disease. J Am Coll Cardiol. 1997;30:1032-1038.
113. Kalman JM, VanHare GF, Olgin JE, Saxon LA, Stark SI, Lesh MD. Ablation of 'incisional' reentrant atrial tachycardia complicating surgery for congenital heart disease: use of entrainment to define a critical isthmus of conduction. Circulation. 1996;93:502-512. doi: 10.1161/01. CIR.93.3.502.
114. Garson A Jr, Bink-Boelkens M, Hesslein PS, Hordof AJ, Keane JF, Neches WH, Porter CJ. Atrial flutter in the young: a collaborative study of 380 cases. J Am Coll Cardiol. 1985;6:871-878.
115. Rhodes LA, Walsh EP, Gamble WJ, Triedman JK, Saul JP. Benefits and potential risks of atrial antitachycardia pacing after repair of congenital heart disease. Pacing Clin Electrophysiol. 1995;18(pt 1):1005-1016.
116. Li W, Somerville J. Atrial flutter in grown-up congenital heart (GUCH) patients: clinical characteristics of affected population. Int J Cardiol. 2000;75:129-137.
117. Walsh EP, Cecchin F. Arrhythmias in adult patients with congenital heart disease. Circulation. 2007;115:534-545. doi: 10.1161/ CIRCULATIONAHA.105.592410.
118. Feltes TF, Friedman RA. Transesophageal echocardiographic detection of atrial thrombi in patients with nonfibrillation atrial tachyarrhythmias and congenital heart disease. J Am Coll Cardiol. 1994;24:1365-1370.
119. Roos-Hesselink J, Perlroth MG, McGhie J, Spitaels S. Atrial arrhythmias in adults after repair of tetralogy of Fallot: correlations with clinical, exercise, and echocardiographic findings. Circulation. 1995;91:2214-2219.
120. Cecchin F, Johnsrude CL, Perry JC, Friedman RA. Effect of age and surgical technique on symptomatic arrhythmias after the Fontan procedure. Am J Cardiol. 1995;76:386-391.
121. Stamm C, Friehs I, Mayer Jr.J.E., Zurakowski D, Triedman JK, Moran AM, Walsh EP, Lock JE, Jonas RA, Del Nido PJ. Long-term results of the lateral tunnel Fontan operation. J Thorac Cardiovasc Surg. 2001;121:28-41.
122. Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA III, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, Hlatky MA, Newby LK, Page RL, Schoenfeld MH, Silka MJ, Stevenson LW, Sweeney MO. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) [published correction appears in Circulation. 2009;120:e34-e35]. Circulation. 2008;117:e350-e408.
123. Stephenson EA, Casavant D, Tuzi J, Alexander ME, Law I, Serwer G, Strieper M, Walsh EP, Berul CI; ATTEST Investigators. Efficacy of atrial antitachycardia pacing using the Medtronic AT500 pacemaker in patients with congenital heart disease. Am J Cardiol. 2003;92:871-876.
124. Mavroudis C, Backer CL, Deal BJ, Johnsrude C, Strasburger J. Total cavopulmonary conversion and maze procedure for patients with failure of the Fontan operation. J Thorac Cardiovasc Surg. 2001;122:863-871. doi: 10.1067/mtc.2001.117840.
125. Kirsh JA, Walsh EP, Triedman JK. Prevalence of and risk factors for atrial fibrillation and intra-atrial reentrant tachycardia among patients with congenital heart disease. Am J Cardiol. 2002;90:338-340.
126. Chandar JS, Wolff GS, Garson A Jr, Bell TJ, Beder SD, Bink-Boelkens M, Byrum CJ, Campbell RM, Deal BJ, Dick M 2nd, Flinn CJ, Gaum WE, Gillette PC, Hordof AJ, Kugler JD, Porter CJ, Walsh EP. Ventricular arrhythmias in postoperative tetralogy of Fallot. Am J Cardiol. 1990;65:655-661.
127. Gillette PC, Garson A Jr. Sudden cardiac death in the pediatric population. Circulation. 1992;85(1 suppl):I64-I69.
128. Nollert G, Fischlein T, Bouterwek S, Böhmer C, Klinner W, Reichart B. Long-term survival in patients with repair of tetralogy of Fallot: 36-year follow-up of 490 survivors of the first year after surgical repair. J Am Coll Cardiol. 1997;30:1374-1383.
129. Gatzoulis K, Carlson MD, Johnson NJ, Biblo LA, Waldo AL. Regular wide QRS complex tachycardia during atrial fibrillation in a patient with preexcitation syndrome: a case report. J Cardiovasc Electrophysiol. 1995;6:493-497.
130. Gatzoulis MA, Balaji S, Webber SA, Siu SC, Hokanson JS, Poile C, Rosenthal M, Nakazawa M, Moller JH, Gillette PC, Webb GD, Redington AN. Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study. Lancet. 2000;356:975-981. doi: 10.1016/S0140-6736(00)02714-8.
131. Alexander ME, Walsh EP, Saul JP, Epstein MR, Triedman JK. Value of programmed ventricular stimulation in patients with congenital heart disease. J Cardiovasc Electrophysiol. 1999;10:1033-1044.
132. Khairy P, Landzberg MJ, Gatzoulis MA, Lucron H, Lambert J, Marçon F, Alexander ME, Walsh EP. Value of programmed ventricular stimulation after tetralogy of Fallot repair: a multicenter study. Circulation. 2004;109:1994-2000. doi: 10.1161/01.CIR.0000126495.11040.BD.
133. Kammeraad JA, van Deurzen CH, Sreeram N, Bink-Boelkens MT, Ottenkamp J, Helbing WA, Lam J, Sobotka-Plojhar MA, Daniels O, Balaji S. Predictors of sudden cardiac death after Mustard or Senning repair for transposition of the great arteries. J Am Coll Cardiol. 2004;44:1095-1102. doi: 10.1016/j.jacc.2004.05.073.
134. Therrien J, Siu SC, Harris L, Dore A, Niwa K, Janousek J, Williams WG, Webb G, Gatzoulis MA. Impact of pulmonary valve replacement on arrhythmia propensity late after repair of tetralogy of Fallot. Circulation. 2001;103:2489-2494. doi: 10.1161/01. CIR.103.20.2489.
135. Burton ME, Leon AR. Radiofrequency catheter ablation of right ventricular outflow tract tachycardia late after complete repair of tetralogy of Fallot using the pace mapping technique. Pacing Clin Electrophysiol. 1993;16:2319-2325.
136. Goldner BG, Cooper R, Blau W, Cohen TJ. Radiofrequency catheter ablation as a primary therapy for treatment of ventricular tachycardia in a patient after repair of tetralogy of Fallot. Pacing Clin Electrophysiol. 1994;17:1441-1446.
137. Gonska BD, Cao K, Raab J, Eigster G, Kreuzer H. Radiofrequency catheter ablation of right ventricular tachycardia late after repair of congenital heart defects. Circulation. 1996;94:1902-1908. doi: 10.1161/01. CIR.94.8.1902.
138. Morwood JG, Triedman JK, Berul CI, Khairy P, Alexander ME, Cecchin F, Walsh EP. Radiofrequency catheter ablation of ventricular tachycardia in children and young adults with congenital heart disease. Heart Rhythm. 2004;1:301-308. doi: 10.1016/j.hrthm.2004.05.009.
139. Alexander ME, Cecchin F, Walsh EP, Triedman JK, Bevilacqua LM, Berul CI. Implications of implantable cardioverter defibrillator therapy in congenital heart disease and pediatrics. J Cardiovasc Electrophysiol. 2004;15:72-76. doi: 10.1046/j.1540-8167.2004.03388.x.
140. Manning PB, Mayer Jr.J.E., Wernovsky G, Fishberger SB, Walsh EP. Staged operation to Fontan increases the incidence of sinoatrial node dysfunction. J Thorac Cardiovasc Surg. 1996;111:833-839.
141. Wong T, Davlouros PA, Li W, Millington-Sanders C, Francis DP, Gatzoulis MA. Mechano-electrical interaction late after Fontan operation: relation between P-wave duration and dispersion, right atrial size, and atrial arrhythmias. Circulation. 2004;109:2319-2325. doi: 10.1161/01.CIR.0000129766.18065.DC.
142. Anderson RH, Becker AE, Arnold R, Wilkinson JL. The conducting tissues in congenitally corrected transposition. Circulation. 1974;50:911-923.
143. Van Praagh R, Papagiannis J, Grönenfelder J, Bartram U, Martanovic P. Pathologic anatomy of corrected transposition of the great arteries: medical and surgical implications. Am Heart J. 1998;135(pt 1):772-785.
144. Thiene G, Wenink AC, Frescura C, Wilkinson JL, Gallucci V, Ho SY, Mazzucco A, Anderson RH. Surgical anatomy and pathology of the conduction tissues in atrioventricular defects. J Thorac Cardiovasc Surg. 1981;82:928-937.
145. Huhta JC, Maloney JD, Ritter DG, Ilstrup DM, Feldt RH. Complete atrioventricular block in patients with atrioventricular discordance. Circulation. 1983;67:1374-1377.
146. Connelly MS, Liu PP, Williams WG, Webb GD, Robertson P, McLaughlin PR. Congenitally corrected transposition of the great arteries in the adult: functional status and complications. J Am Coll Cardiol. 1996;27:1238-1243. doi: 10.1016/0735-1097(95)00567-6.
147. Weindling SN, Saul JP, Gamble WJ, Mayer JE, Wessel D, Walsh EP. Duration of complete atrioventricular block after congenital heart disease surgery. Am J Cardiol. 1998;82:525-527.
148. Wolff GS, Rowland TW, Ellison RC. Surgically induced right bundlebranch block with left anterior hemiblock: an ominous sign in postoperative tetralogy of Fallot. Circulation. 1972;46:587-594.
149. Berul CI, Van Hare GF, Kertesz NJ, Dubin AM, Cecchin F, Collins KK, Cannon BC, Alexander ME, Triedman JK, Walsh EP, Friedman RA. Results of a multicenter retrospective implantable cardioverter-defibrillator registry of pediatric and congenital heart disease patients. J Am Coll Cardiol. 2008;51:1685-1691. doi: 10.1016/j.jacc.2008.01.033.
150. Tracy CM, Epstein AE, Darbar D, Dimarco JP, Dunbar SB, Estes NAM 3rd, Ferguson Jr.T.B., Hammill SC, Karasik PE, Link MS, Marine JE, Schoenfeld MH, Shanker AJ, Silka MJ, Stevenson LW, Stevenson WG, Varosy PD. 2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Circulation. 2012;126:1784-1800. doi: 10.1161/CIR. 0b013e3182618569.
151. Khairy P, Harris L, Landzberg MJ, Viswanathan S, Barlow A, Gatzoulis MA, Fernandes SM, Beauchesne L, Therrien J, Chetaille P, Gordon E, Vonder Muhll I, Cecchin F. Implantable cardioverter-defibrillators in tetralogy of Fallot. Circulation. 2008;117:363-370. doi: 10.1161/ CIRCULATIONAHA.107.726372.
152. Silka MJ, Bar-Cohen Y. Should patients with congenital heart disease and a systemic ventricular ejection fraction less than 30% undergo prophylactic implantation of an ICD? Patients with congenital heart disease and a systemic ventricular ejection fraction less than 30% should undergo prophylactic implantation of an implantable cardioverter defibrillator. Circ Arrhythm Electrophysiol. 2008;1:298-306. doi: 10.1161/ CIRCEP.108.801522.
153. Dubin AM, Janousek J, Rhee E, Strieper MJ, Cecchin F, Law IH, Shannon KM, Temple J, Rosenthal E, Zimmerman FJ, Davis A, Karpawich PP, Al Ahmad A, Vetter VL, Kertesz NJ, Shah M, Snyder C, Stephenson E, Emmel M, Sanatani S, Kanter R, Batra A, Collins KK. Resynchronization therapy in pediatric and congenital heart disease patients: an international multicenter study. J Am Coll Cardiol. 2005;46:2277-2283. doi: 10.1016/j.jacc.2005.05.096.
154. van der Hulst AE, Delgado V, Blom NA, van de Veire NR, Schalij MJ, Bax JJ, Roest AA, Holman ER. Cardiac resynchronization therapy in paediatric and congenital heart disease patients. Eur Heart J. 2011;32:2236-2246. doi: 10.1093/eurheartj/ehr093.
155. van Rooden CJ, Molhoek SG, Rosendaal FR, Schalij MJ, Meinders AE, Huisman MV. Incidence and risk factors of early venous thrombosis associated with permanent pacemaker leads. J Cardiovasc Electrophysiol. 2004;15:1258-1262. doi: 10.1046/j.1540-8167.2004.04081.x.
156. Van Gelder BM, Bracke FA, Oto A, Yildirir A, Haas PC, Seger JJ, Stainback RF, Botman KJ, Meijer A. Diagnosis and management of inadvertently placed pacing and ICD leads in the left ventricle: a multicenter experience and review of the literature. Pacing Clin Electrophysiol. 2000;23:877-883.
157. Knauth AL, Lock JE, Perry SB, McElhinney DB, Gauvreau K, Landzberg MJ, Rome JJ, Hellenbrand WE, Ruiz CE, Jenkins KJ. Transcatheter catheter device closure of congenital and postoperative residual ventricular septal defects. Circulation. 2004;110:501-507.
158. Dimopoulos K, Inuzuka R, Goletto S, Giannakoulas G, Swan L, Wort SJ, Gatzoulis MA. Improved survival among patients with Eisenmenger syndrome receiving advanced therapy for pulmonary arterial hypertension. Circulation. 2010;121:20-25. doi: 10.1161/ CIRCULATIONAHA.109.883876.
159. Manes A, Palazzini M, Leci E, Bacchi Reggiani ML, Branzi A, Galiè N. Current era survival of patients with pulmonary arterial hypertension associated with congenital heart disease: a comparison between clinical subgroups. Eur Heart J. 2014;35:716-724. doi: 10.1093/eurheartj/eht072.
160. Diller GP, Alonso-Gonzalez R, Dimopoulos K, Alvarez-Barredo M, Koo C, Kempny A, Harries C, Parfitt L, Uebing AS, Swan L, Marino PS, Wort SJ, Gatzoulis MA. Disease targeting therapies in patients with Eisenmenger syndrome: response to treatment and long-term efficiency. Int J Cardiol. 2013;167:840-847. doi: 10.1016/j.ijcard.2012.02.007.
161. Tay EL, Peset A, Papaphylactou M, Inuzuka R, Alonso-Gonzalez R, Giannakoulas G, Tzifa A, Goletto S, Broberg C, Dimopoulos K, Gatzoulis MA. Replacement therapy for iron deficiency improves exercise capacity and quality of life in patients with cyanotic congenital heart disease and/or the Eisenmenger syndrome. Int J Cardiol. 2011;151:307-312. doi: 10.1016/j.ijcard.2010.05.066.
162. Schuuring MJ, Vis JC, van Dijk AP, van Melle JP, Vliegen HW, Pieper PG, Sieswerda GT, de Bruin-Bon RH, Mulder BJ, Bouma BJ. Impact of bosentan on exercise capacity in adults after the Fontan procedure: a randomized controlled trial. Eur J Heart Fail. 2013;15:690-698. doi: 10.1093/eurjhf/hft017.
163. Goldberg DJ, French B, McBride MG, Marino BS, Mirarchi N, Hanna BD, Wernovsky G, Paridon SM, Rychik J. Impact of oral sildenafil on exercise performance in children and young adults after the Fontan operation: a randomized, double-blind, placebo-controlled, crossover trial. Circulation. 2011;123:1185-1193. doi: 10.1161/ CIRCULATIONAHA.110.981746.
164. Connolly HM, Huston J 3rd, Brown RD Jr, Warnes CA, Ammash NM, Tajik AJ. Intracranial aneurysms in patients with coarctation of the aorta: a prospective magnetic resonance angiographic study of 100 patients. Mayo Clin Proc. 2003;78:1491-1499. doi: 10.4065/78.12.1491.
165. Rigolin VH, Li JS, Hanson MW, Sullivan MJ, Robiolio PA, Hearne SE, Baker WA, Harrison JK, Bashore TM. Role of right ventricular and pulmonary functional abnormalities in limiting exercise capacity in adults with congenital heart disease. Am J Cardiol. 1997;80:315-322.
166. Fredriksen PM, Veldtman G, Hechter S, Therrien J, Chen A, Warsi MA, Freeman M, Liu P, Siu S, Thaulow E, Webb G. Aerobic capacity in adults with various congenital heart diseases. Am J Cardiol. 2001;87:310-314.
167. Fredriksen PM, Chen A, Veldtman G, Hechter S, Therrien J, Webb G. Exercise capacity in adult patients with congenitally corrected transposition of the great arteries. Heart. 2001;85:191-195.
168. Diller GP, Dimopoulos K, Okonko D, Li W, Babu-Narayan SV, Broberg CS, Johansson B, Bouzas B, Mullen MJ, Poole-Wilson PA, Francis DP, Gatzoulis MA. Exercise intolerance in adult congenital heart disease: comparative severity, correlates, and prognostic implication. Circulation. 2005;112:828-835. doi: 10.1161/CIRCULATIONAHA.104.529800.
169. Pianosi PT, Johnson JN, Turchetta A, Johnson BD. Pulmonary function and ventilatory limitation to exercise in congenital heart disease. Congenit Heart Dis. 2009;4:2-11. doi: 10.1111/j.1747-0803.2008.00244.x.
170. Ginde S, Bartz PJ, Hill GD, Danduran MJ, Biller J, Sowinski J, Tweddell JS, Earing MG. Restrictive lung disease is an independent predictor of exercise intolerance in the adult with congenital heart disease. Congenit Heart Dis. 2013;8:246-254. doi: 10.1111/chd.12010.
171. Fredriksen PM, Therrien J, Veldtman G, Warsi MA, Liu P, Siu S, Williams W, Granton J, Webb G. Lung function and aerobic capacity in adult patients following modified Fontan procedure. Heart. 2001;85:295-299.
172. Mannino DM, Buist AS, Petty TL, Enright PL, Redd SC. Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study. Thorax. 2003;58:388-393.
173. Samánek M, Sulc J, Zapletal A. Lung function in simple complete transposition after intracardiac repair. Int J Cardiol. 1989;24:13-17.
174. Gilljam T, Sixt R. Lung function in relation to haemodynamic status after atrial redirection for transposition of the great arteries. Eur Heart J. 1995;16:1952-1959.
175. Wessel HU, Paul MH. Exercise studies in tetralogy of Fallot: a review. Pediatr Cardiol. 1999;20:39-47.
176. Paul MH, Wessel HU. Exercise studies in patients with transposition of the great arteries after atrial repair operations (Mustard/Senning): a review. Pediatr Cardiol. 1999;20:49-55.
177. Herrera-Soto JA, Vander Have KL, Barry-Lane P, Myers JL. Retrospective study on the development of spinal deformities following sternotomy for congenital heart disease. Spine (Phila Pa 1976). 2007;32:1998-2004. doi: 10.1097/BRS.0b013e318131b225.
178. Alonso-Gonzalez R, Borgia F, Diller GP, Inuzuka R, Kempny A, Martinez-Naharro A, Tutarel O, Marino P, Wustmann K, Charalambides M, Silva M, Swan L, Dimopoulos K, Gatzoulis MA. Abnormal lung function in adults with congenital heart disease: prevalence, relation to cardiac anatomy, and association with survival. Circulation. 2013;127:882-890. doi: 10.1161/CIRCULATIONAHA.112.126755.
179. Martínez-Quintana E, Miranda-Calderín G, Ugarte-Lopetegui A, Rodríguez-González F. Rehabilitation program in adult congenital heart disease patients with pulmonary hypertension. Congenit Heart Dis. 2010;5:44-50. doi: 10.1111/j.1747-0803.2009.00370.x.
180. Dua JS, Cooper AR, Fox KR, Graham Stuart A. Exercise training in adults with congenital heart disease: feasibility and benefits. Int J Cardiol. 2010;138:196-205. doi: 10.1016/j.ijcard.2009.01.038.
181. Asrani SK, Asrani NS, Freese DK, Phillips SD, Warnes CA, Heimbach J, Kamath PS. Congenital heart disease and the liver. Hepatology. 2012;56:1160-1169. doi: 10.1002/hep.25692.
182. Kiesewetter CH, Sheron N, Vettukattill JJ, Hacking N, Stedman B, Millward-Sadler H, Haw M, Cope R, Salmon AP, Sivaprakasam MC, Kendall T, Keeton BR, Iredale JP, Veldtman GR. Hepatic changes in the failing Fontan circulation. Heart. 2007;93:579-584. doi: 10.1136/ hrt.2006.094516.
183. Ginde S, Hohenwalter MD, Foley WD, Sowinski J, Bartz PJ, Venkatapuram S, Weinberg C, Tweddell JS, Earing MG. Noninvasive assessment of liver fibrosis in adult patients following the Fontan procedure. Congenit Heart Dis. 2012;7:235-242. doi: 10.1111/j.1747-0803.2012.00632.x.
184. Rychik J, Veldtman G, Rand E, Russo P, Rome JJ, Krok K, Goldberg DJ, Cahill AM, Wells RG. The precarious state of the liver after a Fontan operation: summary of a multidisciplinary symposium. Pediatr Cardiol. 2012;33:1001-1012. doi: 10.1007/s00246-012-0315-7.
185. Kendall TJ, Stedman B, Hacking N, Haw M, Vettukattill JJ, Salmon AP, Cope R, Sheron N, Millward-Sadler H, Veldtman GR, Iredale JP. Hepatic fibrosis and cirrhosis in the Fontan circulation: a detailed morphological study. J Clin Pathol. 2008;61:504-508. doi: 10.1136/ jcp.2007.052365.
186. Friedrich-Rust M, Koch C, Rentzsch A, Sarrazin C, Schwarz P, Herrmann E, Lindinger A, Sarrazin U, Poynard T, Schäfers HJ, Zeuzem S, Abdul-Khaliq H. Noninvasive assessment of liver fibrosis in patients with Fontan circulation using transient elastography and biochemical fibrosis markers. J Thorac Cardiovasc Surg. 2008;135:560-567. doi: 10.1016/j.jtcvs.2007.09.039.
187. Namasivayam S, Salman K, Mittal PK, Martin D, Small WC. Hypervascular hepatic focal lesions: spectrum of imaging features. Curr Probl Diagn Radiol. 2007;36:107-123. doi: 10.1067/j. cpradiol.2006.12.004.
188. Bryant T, Ahmad Z, Millward-Sadler H, Burney K, Stedman B, Kendall T, Vettukattil J, Haw M, Salmon AP, Cope R, Hacking N, Breen D, Sheron N, Veldtman GR. Arterialised hepatic nodules in the Fontan circulation: hepatico-cardiac interactions. Int J Cardiol. 2011;151:268-272. doi: 10.1016/j.ijcard.2010.05.047.
189. Ghaferi AA, Hutchins GM. Progression of liver pathology in patients undergoing the Fontan procedure: chronic passive congestion, cardiac cirrhosis, hepatic adenoma, and hepatocellular carcinoma. J Thorac Cardiovasc Surg. 2005;129:1348-1352. doi: 10.1016/j.jtcvs.2004.10.005.
190. Liu GJ, Lu MD. Diagnosis of liver cirrhosis with contrast-enhanced ultrasound. World J Radiol. 2010;2:32-36. doi: 10.4329/wjr.v2.i1.32.
191. Sandrasegaran K, Akisik FM, Lin C, Tahir B, Rajan J, Saxena R, Aisen AM. Value of diffusion-weighted MRI for assessing liver fibrosis and cirrhosis. AJR Am J Roentgenol. 2009;193:1556-1560. doi: 10.2214/ AJR.09.2436.
192. Fraquelli M, Rigamonti C, Casazza G, Conte D, Donato MF, Ronchi G, Colombo M. Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease. Gut. 2007;56:968-973. doi: 10.1136/gut.2006.111302.
193. Colli A, Pozzoni P, Berzuini A, Gerosa A, Canovi C, Molteni EE, Barbarini M, Bonino F, Prati D. Decompensated chronic heart failure: increased liver stiffness measured by means of transient elastography. Radiology. 2010;257:872-878. doi: 10.1148/radiol.10100013.
194. Baek JS, Bae EJ, Ko JS, Kim GB, Kwon BS, Lee SY, Noh CI, Park EA, Lee W. Late hepatic complications after Fontan operation: non-invasive markers of hepatic fibrosis and risk factors. Heart. 2010;96:1750-1755. doi: 10.1136/hrt.2010.201772.
195. Chaloupecký V, Svobodová I, Hadacová I, Tomek V, Hucín B, Tláskal T, Janousek J, Reich O, Skovránek J. Coagulation profile and liver function in 102 patients after total cavopulmonary connection at mid term follow up. Heart. 2005;91:73-79. doi: 10.1136/hrt.2003.026419.
196. van Nieuwenhuizen RC, Peters M, Lubbers LJ, Trip MD, Tijssen JG, Mulder BJ. Abnormalities in liver function and coagulation profile following the Fontan procedure. Heart. 1999;82:40-46.
197. Giallourakis CC, Rosenberg PM, Friedman LS. The liver in heart failure. Clin Liver Dis. 2002;6:947-967, viii-ix.
198. Naschitz JE, Slobodin G, Lewis RJ, Zuckerman E, Yeshurun D. Heart diseases affecting the liver and liver diseases affecting the heart. Am Heart J. 2000;140:111-120. doi: 10.1067/mhj.2000.107177.
199. Pereira NL, Shirali G. Cardiac transplant following failed Fontan or Glenn procedures. J Am Coll Cardiol. 2005;46:1374-1375. doi: 10.1016/j.jacc.2005.07.002.
200. Vogt M, Lang T, Frösner G, Klingler C, Sendl AF, Zeller A, Wiebecke B, Langer B, Meisner H, Hess J. Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening. N Engl J Med. 1999;341:866-870. doi: 10.1056/NEJM199909163411202.
201. Wang A, Book WM, McConnell M, Lyle T, Rodby K, Mahle WT. Prevalence of hepatitis C infection in adult patients who underwent congenital heart surgery prior to screening in 1992. Am J Cardiol. 2007;100:1307-1309. doi: 10.1016/j.amjcard.2007.05.059.
202. Shiina Y, Toyoda T, Kawasoe Y, Tateno S, Shirai T, Matsuo K, Mizuno Y, Ai T, Niwa K. The prevalence and risk factors for cholelithiasis and asymptomatic gallstones in adults with congenital heart disease. Int J Cardiol. 2011;152:171-176. doi: 10.1016/j.ijcard.2010.07.011.
203. Dimopoulos K, Diller GP, Koltsida E, Pijuan-Domenech A, Papadopoulou SA, Babu-Narayan SV, Salukhe TV, Piepoli MF, Poole-Wilson PA, Best N, Francis DP, Gatzoulis MA. Prevalence, predictors, and prognostic value of renal dysfunction in adults with congenital heart disease. Circulation. 2008;117:2320-2328. doi: 10.1161/ CIRCULATIONAHA.107.734921.
204. Buelow MW, Dall A, Bartz PJ, Tweddell JS, Sowinski J, Rudd N, Katzmark L, Earing MG. Renal dysfunction is common among adults after palliation for previous tetralogy of Fallot. Pediatr Cardiol. 2013;34:165-169. doi: 10.1007/s00246-012-0408-3.
205. Karkouti K, Wijeysundera DN, Yau TM, Callum JL, Cheng DC, Crowther M, Dupuis JY, Fremes SE, Kent B, Laflamme C, Lamy A, Legare JF, Mazer CD, McCluskey SA, Rubens FD, Sawchuk C, Beattie WS. Acute kidney injury after cardiac surgery: focus on modifiable risk factors. Circulation. 2009;119:495-502. doi: 10.1161/ CIRCULATIONAHA.108.786913.
206. Stafford-Smith M, Patel UD, Phillips-Bute BG, Shaw AD, Swaminathan M. Acute kidney injury and chronic kidney disease after cardiac surgery. Adv Chronic Kidney Dis. 2008;15:257-277. doi: 10.1053/j. ackd.2008.04.006.
207. Dittrich S, Kurschat K, Dähnert I, Vogel M, Möller C, Alexi-Meskishvili V, Lange PE. Renal function after cardiopulmonary bypass surgery in cyanotic congenital heart disease. Int J Cardiol. 2000;73:173-179.
208. Damman K, van Deursen VM, Navis G, Voors AA, van Veldhuisen DJ, Hillege HL. Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease. J Am Coll Cardiol. 2009;53:582-588. doi: 10.1016/j.jacc.2008.08.080.
209. Mullens W, Abrahams Z, Francis GS, Sokos G, Taylor DO, Starling RC, Young JB, Tang WH. Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol. 2009;53:589-596. doi: 10.1016/j.jacc.2008.05.068.
210. Coca SG, Yalavarthy R, Concato J, Parikh CR. Biomarkers for the diagnosis and risk stratification of acute kidney injury: a systematic review. Kidney Int. 2008;73:1008-1016. doi: 10.1038/sj.ki.5002729.
211. Tutarel O, Denecke A, Bode-Böger SM, Martens-Lobenhoffer J, Schieffer B, Westhoff-Bleck M, Kielstein JT. Symmetrical dimethylarginine outperforms CKD-EPI and MDRD-derived eGFR for the assessment of renal function in patients with adult congenital heart disease. Kidney Blood Press Res. 2011;34:41-45. doi: 10.1159/000322614.
212. Buelow MW, Dall A, Regner K, Weinberg C, Bartz PJ, Sowinski J, Rudd N, Katzmark L, Tweddell JS, Earing MG. Urinary interleukin-18 and urinary neutrophil gelatinase-associated lipocalin predict acute kidney injury following pulmonary valve replacement prior to serum creatinine. Congenit Heart Dis. 2012;7:441-447. doi: 10.1111/j.1747-0803.2012.00662.x.
213. Welke KF, Dearani JA, Ghanayem NS, Beland MJ, Shen I, Ebels T. Renal complications associated with the treatment of patients with congenital cardiac disease: consensus definitions from the Multi-Societal Database Committee for Pediatric and Congenital Heart Disease. Cardiol Young. 2008;18(suppl 2):222-225. doi: 10.1017/S1047951108002953.
214. Linet MS, Kim KP, Rajaraman P. Children's exposure to diagnostic medical radiation and cancer risk: epidemiologic and dosimetric considerations. Pediatr Radiol. 2009;39(suppl 1):S4-S26. doi: 10.1007/ s00247-008-1026-3.
215. Preston DL, Cullings H, Suyama A, Funamoto S, Nishi N, Soda M, Mabuchi K, Kodama K, Kasagi F, Shore RE. Solid cancer incidence in atomic bomb survivors exposed in utero or as young children. J Natl Cancer Inst. 2008;100:428-436. doi: 10.1093/jnci/djn045.
216. Onnasch DG, Schröder FK, Fischer G, Kramer HH. Diagnostic reference levels and effective dose in paediatric cardiac catheterization. Br J Radiol. 2007;80:177-185. doi: 10.1259/bjr/19929794.
217. McLaughlin JR, Kreiger N, Sloan MP, Benson LN, Hilditch S, Clarke EA. An historical cohort study of cardiac catheterization during childhood and the risk of cancer. Int J Epidemiol. 1993;22:584-591.
218. Modan B, Keinan L, Blumstein T, Sadetzki S. Cancer following cardiac catheterization in childhood. Int J Epidemiol. 2000;29:424-428.
219. Baysson H, Réhel JL, Boudjemline Y, Petit J, Girodon B, Aubert B, Laurier D, Bonnet D, Bernier MO. Risk of cancer associated with cardiac catheterization procedures during childhood: a cohort study in France. BMC Public Health. 2013;13:266. doi: 10.1186/1471-2458-13-266.
220. Christman MP, Castro-Zarraga M, Defaria Yeh D, Liberthson RR, Bhatt AB. Adequacy of cancer screening in adult women with congenital heart disease. ISRN Cardiol. 2013;2013:827696. doi: 10.1155/2013/827696.
221. Derby CA, Crawford SL, Pasternak RC, Sowers M, Sternfeld B, Matthews KA. Lipid changes during the menopause transition in relation to age and weight: the Study of Women's Health Across the Nation. Am J Epidemiol. 2009;169:1352-1361. doi: 10.1093/aje/kwp043.
222. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J; Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002;288:321-333.
223. Santen RJ, Allred DC, Ardoin SP, Archer DF, Boyd N, Braunstein GD, Burger HG, Colditz GA, Davis SR, Gambacciani M, Gower BA, Henderson VW, Jarjour WN, Karas RH, Kleerekoper M, Lobo RA, Manson JE, Marsden J, Martin KA, Martin L, Pinkerton JV, Rubinow DR, Teede H, Thiboutot DM, Utian WH; Endocrine Society. Postmenopausal hormone therapy: an Endocrine Society scientific statement. J Clin Endocrinol Metab. 2010;95(suppl 1):s1-s66. doi: 10.1210/ jc.2009-2509.
224. Canobbio MM, Perloff JK, Rapkin AJ. Gynecological health of females with congenital heart disease. Int J Cardiol. 2005;98:379-387. doi: 10.1016/j.ijcard.2003.11.021.
225. Levine GN, Steinke EE, Bakaeen FG, Bozkurt B, Cheitlin MD, Conti JB, Foster E, Jaarsma T, Kloner RA, Lange RA, Lindau ST, Maron BJ, Moser DK, Ohman EM, Seftel AD, Stewart WJ; on behalf of the American Heart Association Council on Clinical Cardiology, Council on Cardiovascular Nursing, Council on Cardiovascular Surgery and Anesthesia, and Council on Quality of Care and Outcomes Research. Sexual activity and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2012;125:1058-1072. doi: 10.1161/CIR.0b013e3182447787.
226. Moons P, Van Deyk K, Marquet K, De Bleser L, Budts W, De Geest S. Sexual functioning and congenital heart disease: something to worry about? Int J Cardiol. 2007;121:30-35. doi: 10.1016/j.ijcard.2006.10.020.
227. Cook SC, Arnott LM, Nicholson LM, Cook LR, Sparks EA, Daniels CJ. Erectile dysfunction in men with congenital heart disease. Am J Cardiol. 2008;102:1728-1730. doi: 10.1016/j.amjcard.2008.08.017.
228. Vigl M, Hager A, Bauer U, Niggemeyer E, Wittstock B, Köhn FM, Hess J, Kaemmerer H. Sexuality and subjective wellbeing in male patients with congenital heart disease. Heart. 2009;95:1179-1183. doi: 10.1136/ hrt.2008.156695.
229. Vigl M, Kaemmerer M, Niggemeyer E, Nagdyman N, Seifert-Klauss V, Trigas V, Bauer U, Schneider KT, Berger F, Hess J, Kaemmerer H. Sexuality and reproductive health in women with congenital heart disease. Am J Cardiol. 2010;105:538-541. doi: 10.1016/j. amjcard.2009.10.025.
230. Winter MM, Reisma C, Kedde H, Bouma BJ, Vis JC, Luijendijk P, de Witte P, Zwinderman AH, Vliegen HW, Pieper PG, van Dijk AP, Mulder BJ. Sexuality in adult patients with congenital heart disease and their partners. Am J Cardiol. 2010;106:1163-1168, 1168.e1-8. doi: 10.1016/j.amjcard.2010.06.027.
231. Plassman BL, Langa KM, McCammon RJ, Fisher GG, Potter GG, Burke JR, Steffens DC, Foster NL, Giordani B, Unverzagt FW, Welsh-Bohmer KA, Heeringa SG, Weir DR, Wallace RB. Incidence of dementia and cognitive impairment, not dementia in the United States. Ann Neurol. 2011;70:418-426. doi: 10.1002/ana.22362.
232. Lopez OL, Kuller LH, Becker JT, Dulberg C, Sweet RA, Gach HM, Dekosky ST. Incidence of dementia in mild cognitive impairment in the Cardiovascular Health Study Cognition Study. Arch Neurol. 2007;64:416-420. doi: 10.1001/archneur.64.3.416.
233. van Rijen EH, Utens EM, Roos-Hesselink JW, Meijboom FJ, van Domburg RT, Roelandt JR, Bogers AJ, Verhulst FC. Psychosocial functioning of the adult with congenital heart disease: a 20-33 years followup. Eur Heart J. 2003;24:673-683.
234. Stern Y, Gurland B, Tatemichi TK, Tang MX, Wilder D, Mayeux R. Influence of education and occupation on the incidence of Alzheimer's disease. JAMA. 1994;271:1004-1010.
235. Bittles AH, Glasson EJ. Clinical, social, and ethical implications of changing life expectancy in Down syndrome. Dev Med Child Neurol. 2004;46:282-286.
236. Burt DB, Primeaux-Hart S, Loveland KA, Cleveland LA, Lewis KR, Lesser J, Pearson PL. Aging in adults with intellectual disabilities [published correction appears in Am J Ment Retard. 2005;110:358]. Am J Ment Retard. 2005;110:268-284. doi: 10.1352/0895-8017(2005)110[268:AIA WID]2.0.CO;2.
237. Zigman WB, Lott IT. Alzheimer's disease in Down syndrome: neurobiology and risk. Ment Retard Dev Disabil Res Rev. 2007;13:237-246. doi: 10.1002/mrdd.20163.
238. Sananes R, Manlhiot C, Kelly E, Hornberger LK, Williams WG, MacGregor D, Buncic R, McCrindle BW. Neurodevelopmental outcomes after open heart operations before 3 months of age. Ann Thorac Surg. 2012;93:1577-1583. doi: 10.1016/j.athoracsur.2012.02.011.
239. Brandhagen DJ, Feldt RH, Williams DE. Long-term psychologic implications of congenital heart disease: a 25-year follow-up. Mayo Clin Proc. 1991;66:474-479.
240. Kovacs AH, Saidi AS, Kuhl EA, Sears SF, Silversides C, Harrison JL, Ong L, Colman J, Oechslin E, Nolan RP. Depression and anxiety in adult congenital heart disease: predictors and prevalence. Int J Cardiol. 2009;137:158-164. doi: 10.1016/j.ijcard.2008.06.042.
241. Riley JP, Gabe JP, Cowie MR. Does telemonitoring in heart failure empower patients for self-care? A qualitative study. J Clin Nurs. 2013;22:2444-2455. doi: 10.1111/j.1365-2702.2012.04294.x.
242. Enomoto J, Nakazawa J, Mizuno Y, Shirai T, Ogawa J, Niwa K. Psychosocial factors influencing mental health in adults with congenital heart disease. Circ J. 2013;77:749-755.
243. Harrison JL, Silversides CK, Oechslin EN, Kovacs AH. Healthcare needs of adults with congenital heart disease: study of the patient perspective. J Cardiovasc Nurs. 2011;26:497-503. doi: 10.1097/ JCN.0b013e31820984c9.
244. Ong L, Nolan RP, Irvine J, Kovacs AH. Parental overprotection and heart-focused anxiety in adults with congenital heart disease. Int J Behav Med. 2011;18:260-267. doi: 10.1007/s12529-010-9112-y.
245. Saidi AS, Paolillo J, Fricker FJ, Sears SF, Kovacs AH. Biomedical and psychosocial evaluation of "cured" adults with congenital heart disease. Congenit Heart Dis. 2007;2:44-54. doi: 10.1111/j.1747-0803. 2007.00071.x.
246. Price B. Illness careers: the chronic illness experience. J Adv Nurs. 1996;24:275-279.
247. Pierpont ME, Basson CT, Benson DW Jr, Gelb BD, Giglia TM, Goldmuntz E, McGee G, Sable CA, Srivastava D, Webb CL. Genetic basis for congenital heart defects: current knowledge: a scientific statement from the American Heart Association Congenital Cardiac Defects Committee, Council on Cardiovascular Disease in the Young. Circulation. 2007;115:3015-3038. doi: 10.1161/CIRCULATIONAHA.106.183056.
248. Silversides CK, Marelli A, Beauchesne L, Dore A, Kiess M, Salehian O, Bradley T, Colman J, Connelly M, Harris L, Khairy P, Mital S, Niwa K, Oechslin E, Poirier N, Schwerzmann M, Taylor D, Vonder Muhll I, Baumgartner H, Benson L, Celermajer D, Greutmann M, Horlick E, Landzberg M, Meijboom F, Mulder B, Warnes C, Webb G, Therrien J. Canadian Cardiovascular Society 2009 Consensus Conference on the management of adults with congenital heart disease: executive summary. Can J Cardiol. 2010;26:143-150.
249. Cowan J, Morales A, Dagua J, Hershberger RE. Genetic testing and genetic counseling in cardiovascular genetic medicine: overview and preliminary recommendations. Congest Heart Fail. 2008;14:97-105.
250. Burchill L, Greenway S, Silversides CK, Mital S. Genetic counseling in the adult with congenital heart disease: what is the role? Curr Cardiol Rep. 2011;13:347-355. doi: 10.1007/s11886-011-0188-z.
251. McGrath RJ, Laflamme DJ, Schwartz AP, Stransky M, Moeschler JB. Access to genetic counseling for children with autism, Down syndrome, and intellectual disabilities. Pediatrics. 2009;124(suppl 4):S443-S449. doi: 10.1542/peds.2009-1255Q.
252. Powell KP, Hasegawa L, McWalter K. Expanding roles: a survey of public health genetic counselors. J Genet Couns. 2010;19:593-605. doi: 10.1007/s10897-010-9313-1.
253. Resta R, Biesecker BB, Bennett RL, Blum S, Hahn SE, Strecker MN, Williams JL. A new definition of genetic counseling: National Society of Genetic Counselors' Task Force report. J Genet Couns. 2006;15:77-83.
254. Marelli A, Beauchesne L, Mital S, Therrien J, Silversides CK. Canadian Cardiovascular Society 2009 Consensus Conference on the management of adults with congenital heart disease: introduction. Can J Cardiol. 2010;26:e65-e69.
255. Beauchesne LM, Warnes CA, Connolly HM, Ammash NM, Grogan M, Jalal SM, Michels VV. Prevalence and clinical manifestations of 22q11.2 microdeletion in adults with selected conotruncal anomalies. J Am Coll Cardiol. 2005;45:595-598. doi: 10.1016/j.jacc.2004.10.056.
256. Rivkees SA, Hager K, Hosono S, Wise A, Li P, Rinder HM, Gruen JR. A highly sensitive, high-throughput assay for the detection of Turner syndrome. J Clin Endocrinol Metab. 2011;96:699-705. doi: 10.1210/ jc.2010-1554.
257. McDonald-McGinn DM, Zackai EH. Genetic counseling for the 22q11.2 deletion. Dev Disabil Res Rev. 2008;14:69-74. doi: 10.1002/ ddrr.10.
258. Jamieson CR, van der Burgt I, Brady AF, van Reen M, Elsawi MM, Hol F, Jeffery S, Patton MA, Mariman E. Mapping a gene for Noonan syndrome to the long arm of chromosome 12. Nat Genet. 1994;8:357-360. doi: 10.1038/ng1294-357.
259. Razzaque MA, Nishizawa T, Komoike Y, Yagi H, Furutani M, Amo R, Kamisago M, Momma K, Katayama H, Nakagawa M, Fujiwara Y, Matsushima M, Mizuno K, Tokuyama M, Hirota H, Muneuchi J, Higashinakagawa T, Matsuoka R. Germline gain-of-function mutations in RAF1 cause Noonan syndrome. Nat Genet. 2007;39:1013-1017. doi: 10.1038/ng2078.
260. Roberts AE, Araki T, Swanson KD, Montgomery KT, Schiripo TA, Joshi VA, Li L, Yassin Y, Tamburino AM, Neel BG, Kucherlapati RS. Germline gain-of-function mutations in SOS1 cause Noonan syndrome. Nat Genet. 2007;39:70-74. doi: 10.1038/ng1926.
261. Schubbert S, Zenker M, Rowe SL, Böll S, Klein C, Bollag G, van der Burgt I, Musante L, Kalscheuer V, Wehner LE, Nguyen H, West B, Zhang KY, Sistermans E, Rauch A, Niemeyer CM, Shannon K, Kratz CP. Germline KRAS mutations cause Noonan syndrome [published correction appears in Nat Genet. 2006;38:598]. Nat Genet. 2006;38:331-336. doi: 10.1038/ng1748.
262. Hickey EJ, Mehta R, Elmi M, Asoh K, McCrindle BW, Williams WG, Manlhiot C, Benson L. Survival implications: hypertrophic cardiomyopathy in Noonan syndrome. Congenit Heart Dis. 2011;6:41-47. doi: 10.1111/j.1747-0803.2010.00465.x.
263. Bassett AS, Chow EW. Schizophrenia and 22q11.2 deletion syndrome. Curr Psychiatry Rep. 2008;10:148-157.
264. Billings PR. Genetic nondiscrimination. Nat Genet. 2005;37:559-560. doi: 10.1038/ng0605-559.
265. Javitt GH. Policy implications of genetic testing: not just for geneticists anymore. Adv Chronic Kidney Dis. 2006;13:178-182. doi: 10.1053/j. ackd.2006.01.003.
266. Rantanen E, Hietala M, Kristoffersson U, Nippert I, Schmidtke J, Sequeiros J, Kääriäinen H. What is ideal genetic counselling? A survey of current international guidelines. Eur J Hum Genet. 2008;16:445-452. doi: 10.1038/sj.ejhg.5201983.
267. Vause S, Thorne S, Clarke B. Preconceptual counseling for women with cardiac disease. In: Steer PJ, Gatzoulis M, Baker P, eds. Heart Disease and Pregnancy. London, United Kingdom: RCOG Press; 2006:3-8.
268. Øyen N, Poulsen G, Boyd HA, Wohlfahrt J, Jensen PK, Melbye M. Recurrence of congenital heart defects in families. Circulation. 2009;120:295-301. doi: 10.1161/CIRCULATIONAHA.109.857987.
269. Emanuel R, Somerville J, Inns A, Withers R. Evidence of congenital heart disease in the offspring of parents with atrioventricular defects. Br Heart J. 1983;49:144-147.
270. Gill HK, Splitt M, Sharland GK, Simpson JM. Patterns of recurrence of congenital heart disease: an analysis of 6,640 consecutive pregnancies evaluated by detailed fetal echocardiography. J Am Coll Cardiol. 2003;42:923-929.
271. Beckmann JS, Estivill X, Antonarakis SE. Copy number variants and genetic traits: closer to the resolution of phenotypic to genotypic variability. Nat Rev Genet. 2007;8:639-646. doi: 10.1038/nrg2149.
272. Bertola DR, Pereira AC, de Oliveira PS, Kim CA, Krieger JE. Clinical variability in a Noonan syndrome family with a new PTPN11 gene mutation. Am J Med Genet A. 2004;130A:378-383. doi: 10.1002/ ajmg.a.30270.
273. Hirayama-Yamada K, Kamisago M, Akimoto K, Aotsuka H, Nakamura Y, Tomita H, Furutani M, Imamura S, Takao A, Nakazawa M, Matsuoka R. Phenotypes with GATA4 or NKX2.5 mutations in familial atrial septal defect. Am J Med Genet A. 2005;135:47-52. doi: 10.1002/ajmg.a.30684.
274. Morris CA. Introduction: Williams syndrome. Am J Med Genet C Semin Med Genet. 2010;154C:203-208. doi: 10.1002/ajmg.c.30266.
275. Robinson PN, Booms P, Katzke S, Ladewig M, Neumann L, Palz M, Pregla R, Tiecke F, Rosenberg T. Mutations of FBN1 and genotype-phenotype correlations in Marfan syndrome and related fibrillinopathies. Hum Mutat. 2002;20:153-161. doi: 10.1002/humu.10113.
276. Brassington AM, Sung SS, Toydemir RM, Le T, Roeder AD, Rutherford AE, Whitby FG, Jorde LB, Bamshad MJ. Expressivity of Holt-Oram syndrome is not predicted by TBX5 genotype. Am J Hum Genet. 2003;73:74-85. doi: 10.1086/376436.
277. Goldmuntz E, Driscoll DA, Emanuel BS, McDonald-McGinn D, Mei M, Zackai E, Mitchell LE. Evaluation of potential modifiers of the cardiac phenotype in the 22q11.2 deletion syndrome. Birth Defects Res A Clin Mol Teratol. 2009;85:125-129. doi: 10.1002/bdra.20501.
278. Guttmacher AE, Collins FS. Genomic medicine: a primer. N Engl J Med. 2002;347:1512-1520. doi: 10.1056/NEJMra012240.
279. Choi M, Scholl UI, Ji W, Liu T, Tikhonova IR, Zumbo P, Nayir A, Bakkaloʇlu A, Ozen S, Sanjad S, Nelson-Williams C, Farhi A, Mane S, Lifton RP. Genetic diagnosis by whole exome capture and massively parallel DNA sequencing. Proc Natl Acad Sci U S A. 2009;106:19096-19101. doi: 10.1073/pnas.0910672106.
280. Ng SB, Buckingham KJ, Lee C, Bigham AW, Tabor HK, Dent KM, Huff CD, Shannon PT, Jabs EW, Nickerson DA, Shendure J, Bamshad MJ. Exome sequencing identifies the cause of a mendelian disorder. Nat Genet. 2010;42:30-35. doi: 10.1038/ng.499.
281. Ng SB, Nickerson DA, Bamshad MJ, Shendure J. Massively parallel sequencing and rare disease. Hum Mol Genet. 2010;19(R2):R119-R124. doi: 10.1093/hmg/ddq390.
282. Douglas PS, Khandheria B, Stainback RF, Weissman NJ, Brindis RG, Patel MR, Khandheria B, Alpert JS, Fitzgerald D, Heidenreich P, Martin ET, Messer JV, Miller AB, Picard MH, Raggi P, Reed KD, Rumsfeld JS, Steimle AE, Tonkovic R, Vijayaraghavan K, Weissman NJ, Yeon SB, Brindis RG, Douglas PS, Hendel RC, Patel MR, Peterson E, Wolk MJ, Allen JM. ACCF/ASE/ACEP/ASNC/SCAI/SCCT/SCMR 2007 appropriateness criteria for transthoracic and transesophageal echocardiography: a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American Society of Echocardiography, American College of Emergency Physicians, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and the Society for Cardiovascular Magnetic Resonance. J Am Coll Cardiol. 2007;50:187-204. doi: 10.1016/j.jacc.2007;05.003.
283. Child JS, Collins-Nakai RL, Alpert JS, Deanfield JE, Harris L, McLaughlin P, Miner PD, Webb GD, Williams RG. Task Force 3: workforce description and educational requirements for the care of adults with congenital heart disease. J Am Coll Cardiol. 2001;37:1183-1187.
284. Landzberg MJ, Murphy DJ Jr, Davidson WR Jr, Jarcho JA, Krumholz HM, Mayer Jr.J.E., Mee RB, Sahn DJ, Van Hare GF, Webb GD, Williams RG. Task Force 4: organization of delivery systems for adults with congenital heart disease. J Am Coll Cardiol. 2001;37:1187-1193.
285. Child JS, Freed MD, Mavroudis C, Moodie DS, Tucker AL. Task Force 9: training in the care of adult patients with congenital heart disease. J Am Coll Cardiol. 2008;51:389-393. doi: 10.1016/j.jacc.2007.11.017.
286. Ryan T, Armstrong WF, Khandheria BK; American Society of Echocardiography. Task Force 4: training in echocardiography endorsed by the American Society of Echocardiography. J Am Coll Cardiol. 2008;51:361-367. doi: 10.1016/j.jacc.2007.11.012.
287. Hirsch R, Kilner PJ, Connelly MS, Redington AN, St John Sutton MG, Somerville J. Diagnosis in adolescents and adults with congenital heart disease: prospective assessment of individual and combined roles of magnetic resonance imaging and transesophageal echocardiography. Circulation. 1994;90:2937-2951.
288. Franklin RC, Jacobs JP, Krogmann ON, Béland MJ, Aiello VD, Colan SD, Elliott MJ, William Gaynor J, Kurosawa H, Maruszewski B, Stellin G, Tchervenkov CI, Walters Iii HL, Weinberg P, Anderson RH. Nomenclature for congenital and paediatric cardiac disease: historical perspectives and the International Pediatric and Congenital Cardiac Code. Cardiol Young. 2008;18(suppl 2):70-80. doi: 10.1017/ S1047951108002795.
289. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ; Members of the Chamber Quantification Writing Group. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18:1440-1463.
290. Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K, Solomon SD, Louie EK, Schiller NB. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography. J Am Soc Echocardiogr. 2010;23:685-713. doi: 10.1016/j.echo.2010.05.010.
291. Baumgartner H, Hung J, Bermejo J, Chambers JB, Evangelista A, Griffin BP, Iung B, Otto CM, Pellikka PA, Quinones M; American Society of Echocardiography, European Association of Echocardiography. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice [published correction appears in J Am Soc Echocardiogr. 2009;22:442]. J Am Soc Echocardiogr. 2009;22:1-23. doi: 10.1016/j.echo.2008.11.029.
292. Zoghbi WA, Enriquez-Sarano M, Foster E, Grayburn PA, Kraft CD, Levine RA, Nihoyannopoulos P, Otto CM, Quinones MA, Rakowski H, Stewart WJ, Waggoner A, Weissman NJ; American Society of Echocardiography. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr. 2003;16:777-802. doi: 10.1016/ S0894-7317(03)00335-3.
293. Zoghbi WA, Chambers JB, Dumesnil JG, Foster E, Gottdiener JS, Grayburn PA, Khandheria BK, Levine RA, Marx GR, Miller FA Jr, Nakatani S, Quinones MA, Rakowski H, Rodriguez LL, Swaminathan M, Waggoner AD, Weissman NJ, Zabalgoitia M. Recommendations for evaluation of prosthetic valves with echocardiography and Doppler ultrasound: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Task Force on Prosthetic Valves. J Am Soc Echocardiogr. 2009;22:975-1014. doi: 10.1016/j. echo.2009.07.013.
294. Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA, Waggoner AD, Flachskampf FA, Pellikka PA, Evangelista A. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr. 2009;22:107-133. doi: 10.1016/j.echo.2008.11.023.
295. Lai WW, Geva T, Shirali GS, Frommelt PC, Humes RA, Brook MM, Pignatelli RH, Rychik J; Task Force of the Pediatric Council of the American Society of Echocardiography; Pediatric Council of the American Society of Echocardiography. Guidelines and standards for performance of a pediatric echocardiogram: a report from the Task Force of the Pediatric Council of the American Society of Echocardiography. J Am Soc Echocardiogr. 2006;19:1413-1430. doi: 10.1016/j.echo.2006.09.001.
296. Elhendy A, Mahoney DW, McCully RB, Seward JB, Burger KN, Pellikka PA. Use of a scoring model combining clinical, exercise test, and echocardiographic data to predict mortality in patients with known or suspected coronary artery disease. Am J Cardiol. 2004;93:1223-1228. doi: 10.1016/j.amjcard.2004.01.064.
297. Elhendy A, Modesto KM, Mahoney DW, Khandheria BK, Seward JB, Pellikka PA. Prediction of mortality in patients with left ventricular hypertrophy by clinical, exercise stress, and echocardiographic data. J Am Coll Cardiol. 2003;41:129-135.
298. Koyak Z, Harris L, de Groot JR, Silversides CK, Oechslin EN, Bouma BJ, Budts W, Zwinderman AH, Van Gelder IC, Mulder BJ. Sudden cardiac death in adult congenital heart disease. Circulation. 2012;126:1944-1954. doi: 10.1161/CIRCULATIONAHA.112.104786.
299. Tsang TS. Echocardiography in cardiovascular public health: the Feigenbaum Lecture 2008. J Am Soc Echocardiogr. 2009;22:649-656.
300. Do DH, Therrien J, Marelli A, Martucci G, Afilalo J, Sebag IA. Right atrial size relates to right ventricular end-diastolic pressure in an adult population with congenital heart disease. Echocardiography. 2011;28:109-116. doi: 10.1111/j.1540-8175.2010.01277.x.
301. Ling LF, Obuchowski NA, Rodriguez L, Popovic Z, Kwon D, Marwick TH. Accuracy and interobserver concordance of echocardiographic assessment of right ventricular size and systolic function: a quality control exercise. J Am Soc Echocardiogr. 2012;25:709-713. doi: 10.1016/j. echo.2012.03.018.
302. Morcos P, Vick GW 3rd, Sahn DJ, Jerosch-Herold M, Shurman A, Sheehan FH. Correlation of right ventricular ejection fraction and tricuspid annular plane systolic excursion in tetralogy of Fallot by magnetic resonance imaging. Int J Cardiovasc Imaging. 2009;25:263-270. doi: 10.1007/s10554-008-9387-0.
303. Kutty S, Zhou J, Gauvreau K, Trincado C, Powell AJ, Geva T. Regional dysfunction of the right ventricular outflow tract reduces the accuracy of Doppler tissue imaging assessment of global right ventricular systolic function in patients with repaired tetralogy of Fallot. J Am Soc Echocardiogr. 2011;24:637-643. doi: 10.1016/j. echo.2011.01.020.
304. Grewal J, Majdalany D, Syed I, Pellikka P, Warnes CA. Threedimensional echocardiographic assessment of right ventricular volume and function in adult patients with congenital heart disease: comparison with magnetic resonance imaging. J Am Soc Echocardiogr. 2010;23:127-133. doi: 10.1016/j.echo.2009.11.002.
305. Niemann PS, Pinho L, Balbach T, Galuschky C, Blankenhagen M, Silberbach M, Broberg C, Jerosch-Herold M, Sahn DJ. Anatomically oriented right ventricular volume measurements with dynamic threedimensional echocardiography validated by 3-Tesla magnetic resonance imaging. J Am Coll Cardiol. 2007;50:1668-1676. doi: 10.1016/j. jacc.2007.07.031.
306. Tamborini G, Marsan NA, Gripari P, Maffessanti F, Brusoni D, Muratori M, Caiani EG, Fiorentini C, Pepi M. Reference values for right ventricular volumes and ejection fraction with real-time three-dimensional echocardiography: evaluation in a large series of normal subjects. J Am Soc Echocardiogr. 2010;23:109-115. doi: 10.1016/j.echo.2009.11.026.
307. Margossian R, Schwartz ML, Prakash A, Wruck L, Colan SD, Atz AM, Bradley TJ, Fogel MA, Hurwitz LM, Marcus E, Powell AJ, Printz BF, Puchalski MD, Rychik J, Shirali G, Williams R, Yoo SJ, Geva T; Pediatric Heart Network Investigators. Comparison of echocardiographic and cardiac magnetic resonance imaging measurements of functional single ventricular volumes, mass, and ejection fraction (from the Pediatric Heart Network Fontan Cross-Sectional Study). Am J Cardiol. 2009;104:419-428. doi: 10.1016/j.amjcard.2009.03.058.
308. Diller GP, Kempny A, Liodakis E, Alonso-Gonzalez R, Inuzuka R, Uebing A, Orwat S, Dimopoulos K, Swan L, Li W, Gatzoulis MA, Baumgartner H. Left ventricular longitudinal function predicts lifethreatening ventricular arrhythmia and death in adults with repaired tetralogy of Fallot. Circulation. 2012;125:2440-2446. doi: 10.1161/ CIRCULATIONAHA.111.086983.
309. Kalogeropoulos AP, Deka A, Border W, Pernetz MA, Georgiopoulou VV, Kiani J, McConnell M, Lerakis S, Butler J, Martin RP, Book WM. Right ventricular function with standard and speckle-tracking echocardiography and clinical events in adults with D-transposition of the great arteries post atrial switch. J Am Soc Echocardiogr. 2012;25:304-312. doi: 10.1016/j.echo.2011.12.003.
310. Kutty S, Olson J, Danford CJ, Sandene EK, Xie F, Fletcher SE, Erickson CC, Kugler JD, Danford DA, Porter TR. Ultrasound contrast and realtime perfusion in conjunction with supine bicycle stress echocardiography for comprehensive evaluation of surgically corrected congenital heart disease. Eur Heart J Cardiovasc Imaging. 2012;13:500-509. doi: 10.1093/ejechocard/jer287.
311. Sahn DJ, Allen HD, George W, Mason M, Goldberg SJ. The utility of contrast echocardiographic techniques in the care of critically ill infants with cardiac and pulmonary disease. Circulation. 1977;56:959-968.
312. Van Hare GF, Silverman NH. Contrast two-dimensional echocardiography in congenital heart disease: techniques, indications and clinical utility. J Am Coll Cardiol. 1989;13:673-686.
313. Stewart JA, Fraker TD Jr, Slosky DA, Wise NK, Kisslo JA. Detection of persistent left superior vena cava by two-dimensional contrast echocardiography. J Clin Ultrasound. 1979;7:357-360.
314. Foale R, Bourdillon PD, Somerville J, Rickards A. Anomalous systemic venous return: recognition by two-dimensional echocardiography. Eur Heart J. 1983;4:186-195.
315. Schmidt KG, Silverman NH. Cross-sectional and contrast echocardiography in the diagnosis of interatrial communications through the coronary sinus. Int J Cardiol. 1987;16:193-199.
316. Barzilai B, Waggoner AD, Spessert C, Picus D, Goodenberger D. Twodimensional contrast echocardiography in the detection and follow-up of congenital pulmonary arteriovenous malformations. Am J Cardiol. 1991;68:1507-1510.
317. Moore JW, Kirby WC, Madden WA, Gaither NS. Development of pulmonary arteriovenous malformations after modified Fontan operations. J Thorac Cardiovasc Surg. 1989;98:1045-1050.
318. Chang RK, Alejos JC, Atkinson D, Jensen R, Drant S, Galindo A, Laks H. Bubble contrast echocardiography in detecting pulmonary arteriovenous shunting in children with univentricular heart after cavopulmonary anastomosis. J Am Coll Cardiol. 1999;33:2052-2058.
319. Kronzon I, Tunick PA, Freedberg RS, Trehan N, Rosenzweig BP, Schwinger ME. Transesophageal echocardiography is superior to transthoracic echocardiography in the diagnosis of sinus venosus atrial septal defect. J Am Coll Cardiol. 1991;17:537-542.
320. Ammash NM, Seward JB, Warnes CA, Connolly HM, O'Leary PW, Danielson GK. Partial anomalous pulmonary venous connection: diagnosis by transesophageal echocardiography. J Am Coll Cardiol. 1997;29:1351-1358.
321. Pellikka PA, Nagueh SF, Elhendy AA, Kuehl CA, Sawada SG; American Society of Echocardiography. American Society of Echocardiography recommendations for performance, interpretation, and application of stress echocardiography. J Am Soc Echocardiogr. 2007;20:1021-1041. doi: 10.1016/j.echo.2007.07.003.
322. Magne J, Lancellotti P, Piérard LA. Exercise pulmonary hypertension in asymptomatic degenerative mitral regurgitation. Circulation. 2010;122:33-41. doi: 10.1161/CIRCULATIONAHA.110.938241.
323. Bossone E, Avelar E, Bach DS, Gillespie B, Rubenfire M, Armstrong WF. Diagnostic value of resting tricuspid regurgitation velocity and right ventricular ejection flow parameters for the detection of exercise induced pulmonary arterial hypertension. Int J Card Imaging. 2000;16:429-436.
324. Devereux RB, de Simone G, Arnett DK, Best LG, Boerwinkle E, Howard BV, Kitzman D, Lee ET, Mosley TH Jr, Weder A, Roman MJ. Normal limits in relation to age, body size and gender of two-dimensional echocardiographic aortic root dimensions in persons ≥15 years of age. Am J Cardiol. 2012;110:1189-1194. doi: 10.1016/j.amjcard.2012.05.063.
325. Innelli P, Esposito R, Olibet M, Nistri S, Galderisi M. The impact of ageing on right ventricular longitudinal function in healthy subjects: a pulsed tissue Doppler study. Eur J Echocardiogr. 2009;10:491-498. doi: 10.1093/ejechocard/jen313.
326. Davidson WR Jr, Fee EC. Influence of aging on pulmonary hemodynamics in a population free of coronary artery disease. Am J Cardiol. 1990;65:1454-1458.
327. Weyman AE, Davidoff R, Gardin J, Ryan T, St John Sutton M, Weissman NJ. Echocardiographic evaluation of pulmonary artery pressure with clinical correlates in predominantly obese adults. J Am Soc Echocardiogr. 2002;15:454-462.
328. Duffels MG, Engelfriet PM, Berger RM, van Loon RL, Hoendermis E, Vriend JW, van der Velde ET, Bresser P, Mulder BJ. Pulmonary arterial hypertension in congenital heart disease: an epidemiologic perspective from a Dutch registry. Int J Cardiol. 2007;120:198-204. doi: 10.1016/j. ijcard.2006.09.017.
329. Gardner BI, Bingham SE, Allen MR, Blatter DD, Anderson JL. Cardiac magnetic resonance versus transthoracic echocardiography for the assessment of cardiac volumes and regional function after myocardial infarction: an intrasubject comparison using simultaneous intrasubject recordings. Cardiovasc Ultrasound. 2009;7:38. doi: 10.1186/1476-7120-7-38.
330. Kilner PJ. Imaging congenital heart disease in adults. Br J Radiol. 2011;84 Spec No 3:S258-S268. doi: 10.1259/bjr/74240815.
331. Inglessis I, Abbara S, de Moor M. Which diagnostic modality for adult congenital heart disease? J Cardiovasc Comput Tomogr. 2008;2:23-25. doi: 10.1016/j.jcct.2007.12.009.
332. Ghoshhajra BB, Sidhu MS, El-Sherief A, Rojas C, Yeh DD, Engel LC, Liberthson R, Abbara S, Bhatt A. Adult congenital heart disease imaging with second-generation dual-source computed tomography: initial experiences and findings. Congenit Heart Dis. 2012;7:516-525. doi: 10.1111/chd.12008.
333. Greenwood JP, Maredia N, Younger JF, Brown JM, Nixon J, Everett CC, Bijsterveld P, Ridgway JP, Radjenovic A, Dickinson CJ, Ball SG, Plein S. Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial. Lancet. 2012;379:453-460. doi: 10.1016/S0140-6736(11)61335-4.
334. Kanal E, Barkovich AJ, Bell C, Borgstede JP, Bradley WG Jr, Froelich JW, Gimbel JR, Gosbee JW, Kuhni-Kaminski E, Larson PA, Lester JW Jr, Nyenhuis J, Schaefer DJ, Sebek EA, Weinreb J, Wilkoff BL, Woods TO, Lucey L, Hernandez D. ACR guidance document on MR safe practices: 2013. J Magn Res Imaging. 2013;37:501-530. doi: 10.1002/ jmri.24011.
335. Möller J, Christov F, Schreiber C, Hess J, Hager A. Exercise capacity, quality of life, and daily activity in the long-term follow-up of patients with univentricular heart and total cavopulmonary connection. Eur Heart J. 2009;30:2915-2920. doi: 10.1093/eurheartj/ehp305.
336. Inuzuka R, Diller GP, Borgia F, Benson L, Tay EL, Alonso-Gonzalez R, Silva M, Charalambides M, Swan L, Dimopoulos K, Gatzoulis MA. Comprehensive use of cardiopulmonary exercise testing identifies adults with congenital heart disease at increased mortality risk in the medium term. Circulation. 2012;125:250-259. doi: 10.1161/ CIRCULATIONAHA.111.058719.
337. Winter MM, van der Bom T, de Vries LC, Balducci A, Bouma BJ, Pieper PG, van Dijk AP, van der Plas MN, Picchio FM, Mulder BJ. Exercise training improves exercise capacity in adult patients with a systemic right ventricle: a randomized clinical trial. Eur Heart J. 2012;33:1378-1385. doi: 10.1093/eurheartj/ehr396.
338. Therrien J, Fredriksen P, Walker M, Granton J, Reid GJ, Webb G. A pilot study of exercise training in adult patients with repaired tetralogy of Fallot. Can J Cardiol. 2003;19:685-689.
339. Baumgartner H, Bonhoeffer P, De Groot NM, de Haan F, Deanfield JE, Galie N, Gatzoulis MA, Gohlke-Baerwolf C, Kaemmerer H, Kilner P, Meijboom F, Mulder BJ, Oechslin E, Oliver JM, Serraf A, Szatmari A, Thaulow E, Vouhe PR, Walma E; Task Force on the Management of Grown-up Congenital Heart Disease of the European Society of Cardiology (ESC); Association for European Paediatric Cardiology (AEPC); ESC Committee for Practice Guidelines (CPG). ESC guidelines for the management of grown-up congenital heart disease (new version 2010). Eur Heart J. 2010;31:2915-2957. doi: 10.1093/eurheartj/ ehq249.
340. Frost AE, Quiñones MA, Zoghbi WA, Noon GP. Reversal of pulmonary hypertension and subsequent repair of atrial septal defect after treatment with continuous intravenous epoprostenol. J Heart Lung Transplant. 2005;24:501-503. doi: 10.1016/j.healun.2004.02.004.
341. Cho YH, Jun TG, Yang JH, Park PW, Huh J, Kang IS, Lee HJ. Surgical strategy in patients with atrial septal defect and severe pulmonary hypertension. Heart Surg Forum. 2012;15:E111-E115. doi: 10.1532/ HSF98.20111085.
342. Marelli AJ, Gurvitz M. From numbers to guidelines. Prog Cardiovasc Dis. 2011;53:239-246. doi: 10.1016/j.pcad.2010.10.001.
343. Mowatt G, Cummins E, Waugh N, Walker S, Cook J, Jia X, Hillis GS, Fraser C. Systematic review of the clinical effectiveness and cost-effectiveness of 64-slice or higher computed tomography angiography as an alternative to invasive coronary angiography in the investigation of coronary artery disease. Health Technol Assess. 2008;12:iii-iv, ix-143.
344. Paech DC, Weston AR. A systematic review of the clinical effectiveness of 64-slice or higher computed tomography angiography as an alternative to invasive coronary angiography in the investigation of suspected coronary artery disease. BMC Cardiovasc Disord. 2011;11:32. doi: 10.1186/1471-2261-11-32.
345. Zhang H, Chen Q, Chen LW, Cao H, Zhang GC, Chen DZ. Intraoperative device closure of atrial septal defects in the older population. J Cardiothorac Surg. 2011;6:123. doi: 10.1186/1749-8090-6-123.
346. Thomson JD, Aburawi EH, Watterson KG, Van Doorn C, Gibbs JL. Surgical and transcatheter (Amplatzer) closure of atrial septal defects: a prospective comparison of results and cost. Heart. 2002;87:466-469.
347. Du ZD, Hijazi ZM, Kleinman CS, Silverman NH, Larntz K; Amplatzer Investigators. Comparison between transcatheter and surgical closure of secundum atrial septal defect in children and adults: results of a multicenter nonrandomized trial. J Am Coll Cardiol. 2002;39:1836-1844.
348. Hughes ML, Maskell G, Goh TH, Wilkinson JL. Prospective comparison of costs and short term health outcomes of surgical versus device closure of atrial septal defect in children. Heart. 2002;88:67-70.
349. Murphy JG, Gersh BJ, McGoon MD, Mair DD, Porter CJ, Ilstrup DM, McGoon DC, Puga FJ, Kirklin JW, Danielson GK. Long-term outcome after surgical repair of isolated atrial septal defect: follow-up at 27 to 32 years. N Engl J Med. 1990;323:1645-1650. doi: 10.1056/ NEJM199012133232401.
350. Jemielity M, Dyszkiewicz W, Paluszkiewicz L, Perek B, Buczkowski P, Ponizyński A. Do patients over 40 years of age benefit from surgical closure of atrial septal defects? Heart. 2001;85:300-303.
351. Attie F, Rosas M, Granados N, Zabal C, Buendía A, Calderón J. Surgical treatment for secundum atrial septal defects in patients <40 years old: a randomized clinical trial. J Am Coll Cardiol. 2001;38:2035-2042.
352. Mascio CE, Pasquali SK, Jacobs JP, Jacobs ML, Austin EH 3rd. Outcomes in adult congenital heart surgery: analysis of the Society of Thoracic Surgeons database. J Thorac Cardiovasc Surg. 2011;142:1090-1097. doi: 10.1016/j.jtcvs.2011.07.028.
353. Hopkins RA, Bert AA, Buchholz B, Guarino K, Meyers M. Surgical patch closure of atrial septal defects. Ann Thorac Surg. 2004;77:2144-2149. doi: 10.1016/j.athoracsur.2003.10.105.
354. Price J, Svensson LG. Indications for repair of the aneurysmal aorta. Semin Thorac Cardiovasc Surg. 2012;24:261-266. doi: 10.1053/j. semtcvs.2012.12.001.
355. Bonow RO. Bicuspid aortic valves and dilated aortas: a critical review of the ACC/AHA practice guidelines recommendations. Am J Cardiol. 2008;102:111-114. doi: 10.1016/j.amjcard.2008.01.058.
356. Stamou SC, Hagberg RC, Khabbaz KR, Stiegel MR, Reames MK, Skipper E, Nussbaum M, Lobdell KW. Is advanced age a contraindication for emergent repair of acute type A aortic dissection? Interact Cardiovasc Thorac Surg. 2010;10:539-544. doi: 10.1510/icvts.2009.222984.
357. Ashikhmina EA, Schaff HV, Dearani JA, Sundt TM 3rd, Suri RM, Park SJ, Burkhart HM, Li Z, Daly RC. Aortic valve replacement in the elderly: determinants of late outcome. Circulation. 2011;124:1070-1078. doi: 10.1161/CIRCULATIONAHA.110.987560.
358. Brown JW, Fehrenbacher JW, Ruzmetov M, Shahriari A, Miller J, Turrentine MW. Ross root dilation in adult patients: is preoperative aortic insufficiency associated with increased late autograft reoperation? Ann Thorac Surg. 2011;92:74-81. doi: 10.1016/j.athoracsur.2011.02.012.
359. Brown JW, Ruzmetov M, Shahriari A, Rodefeld MD, Mahomed Y, Turrentine MW. Midterm results of Ross aortic valve replacement: a single-institution experience. Ann Thorac Surg. 2009;88:601-607. doi: 10.1016/j.athoracsur.2009.05.014.
360. Brown JW, Ruzmetov M, Shahriari A, Rodefeld MD, Turrentine MW, Mahomed Y. The Ross full root replacement in adults with bicuspid aortic valve disease. J Heart Valve Dis. 2011;20:332-339.
361. Mokhles MM, Rizopoulos D, Andrinopoulou ER, Bekkers JA, Roos-Hesselink JW, Lesaffre E, Bogers AJ, Takkenberg JJ. Autograft and pulmonary allograft performance in the second post-operative decade after the Ross procedure: insights from the Rotterdam Prospective Cohort Study. Eur Heart J. 2012;33:2213-2224. doi: 10.1093/ eurheartj/ehs173.
362. Haramati LB, Moche IE, Rivera VT, Patel PV, Heyneman L, McAdams HP, Issenberg HJ, White CS. Computed tomography of partial anomalous pulmonary venous connection in adults. J Comput Assist Tomogr. 2003;27:743-749.
363. Said SM, Burkhart HM, Dearani JA, Eidem B, Stensrud P, Phillips SD, Schaff HV. Outcome of caval division techniques for partial anomalous pulmonary venous connections to the superior vena cava. Ann Thorac Surg. 2011;92:980-984. doi: 10.1016/j.athoracsur.2011.04.110.
364. Shahriari A, Rodefeld MD, Turrentine MW, Brown JW. Caval division technique for sinus venosus atrial septal defect with partial anomalous pulmonary venous connection. Ann Thorac Surg. 2006;81:224-229. doi: 10.1016/j.athoracsur.2005.07.015.
365. Moran AM, Hornberger LK, Jonas RA, Keane JF. Development of a double-chambered right ventricle after repair of tetralogy of Fallot. J Am Coll Cardiol. 1998;31:1127-1133.
366. McElhinney DB, Chatterjee KM, Reddy VM. Double-chambered right ventricle presenting in adulthood. Ann Thorac Surg. 2000;70:124-127.
367. Poirier NC, Yu JH, Brizard CP, Mee RB. Long-term results of left ventricular reconditioning and anatomic correction for systemic right ventricular dysfunction after atrial switch procedures. J Thorac Cardiovasc Surg. 2004;127:975-981. doi: 10.1016/j.jtcvs.2003.10.024.
368. Devaney EJ, Charpie JR, Ohye RG, Bove EL. Combined arterial switch and Senning operation for congenitally corrected transposition of the great arteries: patient selection and intermediate results. J Thorac Cardiovasc Surg. 2003;125:500-507. doi: 10.1067/mtc.2003.158.
369. Murtuza B, Barron DJ, Stumper O, Stickley J, Eaton D, Jones TJ, Brawn WJ. Anatomic repair for congenitally corrected transposition of the great arteries: a single-institution 19-year experience. J Thorac Cardiovasc Surg. 2011;142:1348-1357.e1. doi: 10.1016/j.jtcvs.2011.08.016.
370. Dobson R, Danton M, Nicola W, Hamish W. The natural and unnatural history of the systemic right ventricle in adult survivors. J Thorac Cardiovasc Surg. 2013;145:1493-1501. doi: 10.1016/j. jtcvs.2013.02.030.
371. Scherptong RW, Vliegen HW, Winter MM, Holman ER, Mulder BJ, van der Wall EE, Hazekamp MG. Tricuspid valve surgery in adults with a dysfunctional systemic right ventricle: repair or replace? Circulation. 2009;119:1467-1472. doi: 10.1161/CIRCULATIONAHA.108.805135.
372. Acar P, Sidi D, Bonnet D, Aggoun Y, Bonhoeffer P, Kachaner J. Maintaining tricuspid valve competence in double discordance: a challenge for the paediatric cardiologist. Heart. 1998;80:479-483.
373. Winlaw DS, McGuirk SP, Balmer C, Langley SM, Griselli M, Stömper O, De Giovanni JV, Wright JG, Thorne S, Barron DJ, Brawn WJ. Intention-to-treat analysis of pulmonary artery banding in conditions with a morphological right ventricle in the systemic circulation with a view to anatomic biventricular repair. Circulation. 2005;111:405-411. doi: 10.1161/01.CIR.0000153355.92687.FA.
374. Cools B, Brown SC, Louw J, Heying R, Meyns B, Gewillig M. Pulmonary artery banding as "open end" palliation of systemic right ventricles: an interim analysis. Eur J Cardiothorac Surg. 2012;41:913-918. doi: 10.1093/ejcts/ezr078.
375. Langley SM, Winlaw DS, Stumper O, Dhillon R, De Giovanni JV, Wright JG, Miller P, Sethia B, Barron DJ, Brawn WJ. Midterm results after restoration of the morphologically left ventricle to the systemic circulation in patients with congenitally corrected transposition of the great arteries. J Thorac Cardiovasc Surg. 2003;125:1229-1241.
376. Kiesewetter C, Michael K, Morgan J, Veldtman GR. Left ventricular dysfunction after cardiac resynchronization therapy in congenital heart disease patients with a failing systemic right ventricle. Pacing Clin Electrophysiol. 2008;31:159-162. doi: 10.1111/j.1540-8159.2007.00963.x.
377. Khairy P, Fournier A, Thibault B, Dubuc M, Thérien J, Vobecky SJ. Cardiac resynchronization therapy in congenital heart disease. Int J Cardiol. 2006;109:160-168. doi: 10.1016/j.ijcard.2005.06.065.
378. Danielson GK, Driscoll DJ, Mair DD, Warnes CA, Oliver WC Jr. Operative treatment of Ebstein's anomaly. J Thorac Cardiovasc Surg. 1992;104:1195-1202.
379. Dearani JA, Danielson GK. Surgical management of Ebstein's anomaly in the adult. Semin Thorac Cardiovasc Surg. 2005;17:148-154. doi: 10.1053/j.semtcvs.2005.02.008.
380. da Silva JP, Baumgratz JF, da Fonseca L, Franchi SM, Lopes LM, Tavares GM, Soares AM, Moreira LF, Barbero-Marcial M. The cone reconstruction of the tricuspid valve in Ebstein's anomaly: the operation: early and midterm results. J Thorac Cardiovasc Surg. 2007;133:215-223. doi: 10.1016/j.jtcvs.2006.09.018.
381. Dearani JA, Said SM, Burkhart HM, Pike RB, O'Leary PW, Cetta F. Strategies for tricuspid re-repair in Ebstein malformation using the cone technique. Ann Thorac Surg. 2013;96:202-208. doi: 10.1016/j. athoracsur.2013.02.067.
382. Dearani JA, Said SM, O'Leary PW, Burkhart HM, Barnes RD, Cetta F. Anatomic repair of Ebstein's malformation: lessons learned with cone reconstruction. Ann Thorac Surg. 2013;95:220-226. doi: 10.1016/j. athoracsur.2012.04.146.
383. Iscan ZH, Vural KM, Bahar I, Mavioglu L, Saritas A. What to expect after tricuspid valve replacement? Long-term results. Eur J Cardiothorac Surg. 2007;32:296-300. doi: 10.1016/j.ejcts.2007.05.003.
384. Davies JE, Burkhart HM, Dearani JA, Suri RM, Phillips SD, Warnes CA, Sundt TM 3rd, Schaff HV. Surgical management of anomalous aortic origin of a coronary artery. Ann Thorac Surg. 2009;88:844-847. doi: 10.1016/j.athoracsur.2009.06.007.
385. Romp RL, Herlong JR, Landolfo CK, Sanders SP, Miller CE, Ungerleider RM, Jaggers J. Outcome of unroofing procedure for repair of anomalous aortic origin of left or right coronary artery. Ann Thorac Surg. 2003;76:589-595.
386. Therrien J, Siu SC, McLaughlin PR, Liu PP, Williams WG, Webb GD. Pulmonary valve replacement in adults late after repair of tetralogy of Fallot: are we operating too late? J Am Coll Cardiol. 2000;36:1670-1675.
387. Therrien J, Provost Y, Merchant N, Williams W, Colman J, Webb G. Optimal timing for pulmonary valve replacement in adults after tetralogy of Fallot repair. Am J Cardiol. 2005;95:779-782. doi: 10.1016/j. amjcard.2004.11.037.
388. Stephenson EA, Redington AN. Reduction of QRS duration following pulmonary valve replacement in tetralogy of Fallot: implications for arrhythmia reduction? Eur Heart J. 2005;26:863-864. doi: 10.1093/ eurheartj/ehi206.
389. Lim C, Lee JY, Kim WH, Kim SC, Song JY, Kim SJ, Choh JH, Kim CW. Early replacement of pulmonary valve after repair of tetralogy: is it really beneficial? Eur J Cardiothorac Surg. 2004;25:728-734. doi: 10.1016/j.ejcts.2004.01.036.
390. Cheung MM, Konstantinov IE, Redington AN. Late complications of repair of tetralogy of Fallot and indications for pulmonary valve replacement. Semin Thorac Cardiovasc Surg. 2005;17:155-159. doi: 10.1053/j. semtcvs.2005.02.006.
391. Ilbawi MN, Idriss FS, DeLeon SY, Muster AJ, Gidding SS, Berry TE, Paul MH. Factors that exaggerate the deleterious effects of pulmonary insufficiency on the right ventricle after tetralogy repair: surgical implications. J Thorac Cardiovasc Surg. 1987;93:36-44.
392. Lee C, Kim YM, Lee CH, Kwak JG, Park CS, Song JY, Shim WS, Choi EY, Lee SY, Baek JS. Outcomes of pulmonary valve replacement in 170 patients with chronic pulmonary regurgitation after relief of right ventricular outflow tract obstruction: implications for optimal timing of pulmonary valve replacement. J Am Coll Cardiol. 2012;60:1005-1014. doi: 10.1016/j. jacc.2012.03.077.
393. Fiore AC, Brown JW, Turrentine MW, Ruzmetov M, Huynh D, Hanley S, Rodefeld MD. A bovine jugular vein conduit: a ten-year bi-institutional experience. Ann Thorac Surg. 2011;92:183-190. doi: 10.1016/j. athoracsur.2011.02.073.
394. Gatzoulis MA, Till JA, Somerville J, Redington AN. Mechanoelectrical interaction in tetralogy of Fallot: QRS prolongation relates to right ventricular size and predicts malignant ventricular arrhythmias and sudden death. Circulation. 1995;92:231-237.
395. Hennein HA, Mosca RS, Urcelay G, Crowley DC, Bove EL. Intermediate results after complete repair of tetralogy of Fallot in neonates. J Thorac Cardiovasc Surg. 1995;109:332-342, 344.
396. Karamlou T, Silber I, Lao R, McCrindle BW, Harris L, Downar E, Webb GD, Colman JM, Van Arsdell GS, Williams WG. Outcomes after late reoperation in patients with repaired tetralogy of Fallot: the impact of arrhythmia and arrhythmia surgery. Ann Thorac Surg. 2006;81:1786-1793. doi: 10.1016/j.athoracsur.2005.12.039.
397. Karamlou T, McCrindle BW, Williams WG. Surgery insight: late complications following repair of tetralogy of Fallot and related surgical strategies for management. Nat Clin Pract Cardiovasc Med. 2006;3:611-622. doi: 10.1038/ncpcardio0682.
398. Alsoufi B, Williams WG, Hua Z, Cai S, Karamlou T, Chan CC, Coles JG, Van Arsdell GS, Caldarone CA. Surgical outcomes in the treatment of patients with tetralogy of Fallot and absent pulmonary valve. Eur J Cardiothorac Surg. 2007;31:354-359.
399. van Huysduynen BH, van Straten A, Swenne CA, Maan AC, van Eck HJ, Schalij MJ, van der Wall EE, de Roos A, Hazekamp MG, Vliegen HW. Reduction of QRS duration after pulmonary valve replacement in adult Fallot patients is related to reduction of right ventricular volume. Eur Heart J. 2005;26:928-932. doi: 10.1093/eurheartj/ehi140.
400. Alexiou C, Chen Q, Galogavrou M, Gnanapragasam J, Salmon AP, Keeton BR, Haw MP, Monro JL. Repair of tetralogy of Fallot in infancy with a transventricular or a transatrial approach. Eur J Cardiothorac Surg. 2002;22:174-183.
401. Bove EL, Kavey RE, Byrum CJ, Sondheimer HM, Blackman MS, Thomas FD. Improved right ventricular function following late pulmonary valve replacement for residual pulmonary insufficiency or stenosis. J Thorac Cardiovasc Surg. 1985;90:50-55.
402. Lurz P, Coats L, Khambadkone S, Nordmeyer J, Boudjemline Y, Schievano S, Muthurangu V, Lee TY, Parenzan G, Derrick G, Cullen S, Walker F, Tsang V, Deanfield J, Taylor AM, Bonhoeffer P. Percutaneous pulmonary valve implantation: impact of evolving technology and learning curve on clinical outcome. Circulation. 2008;117:1964-1972. doi: 10.1161/CIRCULATIONAHA.107.735779.
403. Zahn EM, Hellenbrand WE, Lock JE, McElhinney DB. Implantation of the Melody transcatheter pulmonary valve in patients with a dysfunctional right ventricular outflow tract conduit: early results from the U.S. clinical trial. J Am Coll Cardiol. 2009;54:1722-1729. doi: 10.1016/j. jacc.2009.06.034.
404. Khambadkone S, Coats L, Taylor A, Boudjemline Y, Derrick G, Tsang V, Cooper J, Muthurangu V, Hegde SR, Razavi RS, Pellerin D, Deanfield J, Bonhoeffer P. Percutaneous pulmonary valve implantation in humans: results in 59 consecutive patients. Circulation. 2005;112:1189-1197. doi: 10.1161/CIRCULATIONAHA.104.523266.
405. Karamlou T, Blackstone EH, Hawkins JA, Jacobs ML, Kanter KR, Brown JW, Mavroudis C, Caldarone CA, Williams WG, McCrindle BW; Pulmonary Conduit Working Group for the Members of the Congenital Heart Surgeons Society. Can pulmonary conduit dysfunction and failure be reduced in infants and children less than age 2 years at initial implantation? J Thorac Cardiovasc Surg. 2006;132:829-838. doi: 10.1016/j. jtcvs.2006.06.034.
406. Poynter JA, Eghtesady P, McCrindle BW, Walters HL 3rd, Kirshbom PM, Blackstone EH, Husain SA, Overman DM, Austin EH, Karamlou T, Lodge AJ, St Louis JD, Gruber PJ, Ziemer G, Davies RR, Jacobs JP, Brown JW, Williams WG, Tchervenkov CI, Jacobs ML, Caldarone CA; Congenital Heart Surgeons' Society. Association of pulmonary conduit type and size with durability in infants and young children. Ann Thorac Surg. 2013;96:1695-1701. doi: 10.1016/j.athoracsur.2013.05.074.
407. Karamlou T, Diggs BS, Person T, Ungerleider RM, Welke KF. National practice patterns for management of adult congenital heart disease: operation by pediatric heart surgeons decreases inhospital death. Circulation. 2008;118:2345-2352. doi: 10.1161/ CIRCULATIONAHA.108.776963.
408. McElhinney DB. Beyond indications: postmarket surveillance and the importance of expanded and off-label use of transcatheter devices in structural and congenital interventions. Circ Cardiovasc Interv. 2012;5:739-740. doi: 10.1161/CIRCINTERVENTIONS.112.976043.
409. Gillespie MJ, Rome JJ, Levi DS, Williams RJ, Rhodes JF, Cheatham JP, Hellenbrand WE, Jones TK, Vincent JA, Zahn EM, McElhinney DB. Melody valve implant within failed bioprosthetic valves in the pulmonary position: a multicenter experience. Circ Cardiovasc Interv. 2012;5:862-870. doi: 10.1161/CIRCINTERVENTIONS.112.972216.
410. Coats L, Tsang V, Khambadkone S, van Doorn C, Cullen S, Deanfield J, de Leval MR, Bonhoeffer P. The potential impact of percutaneous pulmonary valve stent implantation on right ventricular outflow tract re-intervention. Eur J Cardiothorac Surg. 2005;27:536-543. doi: 10.1016/j. ejcts.2004.12.053.
411. Nordmeyer J, Khambadkone S, Coats L, Schievano S, Lurz P, Parenzan G, Taylor AM, Lock JE, Bonhoeffer P. Risk stratification, systematic classification, and anticipatory management strategies for stent fracture after percutaneous pulmonary valve implantation. Circulation. 2007;115:1392-1397. doi: 10.1161/CIRCULATIONAHA.106.674259.
412. Lang P, Chipman CW, Siden H, Williams RG, Norwood WI, Castaneda AR. Early assessment of hemodynamic status after repair of tetralogy of Fallot: a comparison of 24 hour (intensive care unit) and 1 year postoperative data in 98 patients. Am J Cardiol. 1982;50:795-799.
413. Kogon B, Patel M, Leong T, McConnell M, Book W. Management of moderate functional tricuspid valve regurgitation at the time of pulmonary valve replacement: is concomitant tricuspid valve repair necessary? Pediatr Cardiol. 2010;31:843-848. doi: 10.1007/s00246-010-9717-6.
414. Kobayashi J, Kawashima Y, Matsuda H, Nakano S, Miura T, Tokuan Y, Arisawa J. Prevalence and risk factors of tricuspid regurgitation after correction of tetralogy of Fallot. J Thorac Cardiovasc Surg. 1991;102:611-616.
415. Hachiro Y, Takagi N, Koyanagi T, Abe T. Reoperation for tricuspid regurgitation after total correction of tetralogy of Fallot. Ann Thorac Cardiovasc Surg. 2002;8:199-203.
416. Dearani JA, Mavroudis C, Quintessenza J, Deal BJ, Backer CL, Fitzgerald P, Connolly HM, Jacobs JP. Surgical advances in the treatment of adults with congenital heart disease. Curr Opin Pediatr. 2009;21:565-572. doi: 10.1097/MOP.0b013e3283303fa7.
417. Frigiola A, Redington AN, Cullen S, Vogel M. Pulmonary regurgitation is an important determinant of right ventricular contractile dysfunction in patients with surgically repaired tetralogy of Fallot. Circulation. 2004;110(11 suppl 1): II153-II157. doi: 10.1161/01.CIR.0000138397.60956.c2.
418. Bull K, Somerville J, Ty E, Spiegelhalter D. Presentation and attrition in complex pulmonary atresia. J Am Coll Cardiol. 1995;25:491-499.
419. Niwa K, Siu SC, Webb GD, Gatzoulis MA. Progressive aortic root dilatation in adults late after repair of tetralogy of Fallot. Circulation. 2002;106:1374-1378.
420. Karamlou T, Poynter JA, Walters HL 3rd, Rhodes J, Bondarenko I, Pasquali SK, Fuller SM, Lambert LM, Blackstone EH, Jacobs ML, Duncan K, Caldarone CA, Williams WG, McCrindle BW. Long-term functional health status and exercise test variables for patients with pulmonary atresia with intact ventricular septum: a Congenital Heart Surgeons Society study. J Thorac Cardiovasc Surg. 2013;145:1018-1025. doi: 10.1016/j.jtcvs.2012.11.092.
421. Karamlou T, Diggs BS, Ungerleider RM, Welke KF. Evolution of treatment options and outcomes for hypoplastic left heart syndrome over an 18-year period. J Thorac Cardiovasc Surg. 2010;139:119-126. doi: 10.1016/j.jtcvs.2009.04.061.
422. Petko M, Myung RJ, Wernovsky G, Cohen MI, Rychik J, Nicolson SC, Gaynor JW, Spray TL. Surgical reinterventions following the Fontan procedure. Eur J Cardiothorac Surg. 2003;24:255-259.